1
|
Cameron K, Borahay M, Hong X, Baker V, Vaught A, Wang X. Uterine fibroids and risk of hypertensive disorders of pregnancy - results from a racially diverse high-risk cohort. medRxiv 2024:2024.03.05.24303830. [PMID: 38496516 PMCID: PMC10942496 DOI: 10.1101/2024.03.05.24303830] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Abstract] [Grants] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 03/19/2024]
Abstract
Study Question What is the impact of the presence of uterine fibroids on the risk of developing hypertensive disorders of pregnancy (HDP) in a predominantly urban, low-income, Black, and Hispanic population of women with ultrasound or clinically diagnosed uterine fibroids with rich phenotypic data to carefully control for potential confounders? Summary answers The odds of HDP were 39% higher in women with uterine fibroids compared to those without when controlled for age at delivery, race, prepregnancy BMI, education, parity, and smoking status; neither fibroid location or size modified this risk. What is known already Studies are conflicting regarding the impact of uterine fibroids on risk of HDP; limitations of prior studies include primarily Western European populations and lack of measurement of potential confounders. Study design size and duration A total of 7030 women from the Boston Birth Cohort (a racially diverse cohort recruited from 1998 to 2018) that had clinical and ultrasound data regarding uterine fibroid status were included in this analysis. Participants/materials setting and methods Four hundred eighty-nine women with uterine fibroids and 6541 women without were included. Hypertensive disorders of pregnancy were ascertained from medical records. Logistic regression was performed to assess the risk of HDP in women with and without uterine fibroids. Covariates adjusted for included age at delivery, race, pre-pregnancy BMI, education, parity, and smoking status during pregnancy. Sub-analyses were performed to assess the impact of specific fibroid location and overall fibroid volume burden. Main results and the role of chance The incidence of uterine fibroids in the cohort was 7% (N=489). Twelve percent of women without uterine fibroids and 17% of women with fibroids developed HDP; in multivariate analyses adjusted for the potential confounders above, the odds of HDP were 39% higher in women with uterine fibroids compared to those without (p=0.03). Women with a uterine fibroid diagnosis based on ICD code (n=297) versus asymptomatic incidental ultrasound diagnosis (n=192) had a significantly greater chance of developing HDP (20 vs 15%, p=0.006). There did not appear to be an association between number of fibroids or total fibroid volume and the risk of developing HDP. Limitations, reasons for caution: This study has a relatively small sample size. While post-hoc power calculation determined that there was adequate power to detect a 4.6% difference in the incidence of development of HDP between participants with uterine fibroids and those without, the sub-analyses based on fibroid size, location, and method of diagnosis were underpowered to determine a similar level of difference. Wider implications of the findings In a racially diverse cohort, presence of uterine fibroids was a significant risk factor for developing HDP, regardless of uterine fibroid size or location. This may have implications for additional monitoring and risk stratification in women with uterine fibroids. Study funding/competing interests KC supported by WRHR NIH NICHD Award # K12 HD103036, PI Andrew Satin, RD James Segars. The Boston Birth Cohort (the parent study) was supported in part by the National Institutes of Health (NIH) grants (2R01HD041702, R01HD098232, R01ES031272, R01ES031521, and U01 ES034983); and the Health Resources and Services Administration (HRSA) of the U.S. Department of Health and Human Services (HHS) (UT7MC45949). This information or content and conclusions are those of the authors and should not be construed as the official position or policy of, nor should any endorsements be inferred by any funding agencies. Trial registration number The BBC is registered under clinicaltrials.gov NCT03228875 .
Collapse
|
2
|
Wang Y, Hong X, Cao W, Lv J, Yu C, Huang T, Sun D, Liao C, Pang Y, Pang Z, Yu M, Wang H, Wu X, Liu Y, Gao W, Li L. Age effect on the shared etiology of glycemic traits and serum lipids: evidence from a Chinese twin study. J Endocrinol Invest 2024; 47:535-546. [PMID: 37524979 DOI: 10.1007/s40618-023-02164-7] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 01/27/2023] [Accepted: 07/24/2023] [Indexed: 08/02/2023]
Abstract
PURPOSE Diabetes and dyslipidemia are among the most common chronic diseases with increasing global disease burdens, and they frequently occur together. The study aimed to investigate differences in the heritability of glycemic traits and serum lipid indicators and differences in overlapping genetic and environmental influences between them across age groups. METHODS This study included 1189 twin pairs from the Chinese National Twin Registry and divided them into three groups: aged ≤ 40, 41-50, and > 50 years old. Univariate and bivariate structural equation models (SEMs) were conducted on glycemic indicators and serum lipid indicators, including blood glucose (GLU), glycated hemoglobin A1c (HbA1c), total cholesterol (TC), triglycerides (TG), low-density lipoprotein cholesterol (LDL-C) and high-density lipoprotein cholesterol (HDL-C), in the total sample and three age groups. RESULTS All phenotypes showed moderate to high heritability (0.37-0.64). The heritability of HbA1c demonstrated a downward trend with age (HbA1c: 0.50-0.79), while others remained relatively stable (GLU: 0.55-0.62, TC: 0.58-0.66, TG: 0.50-0.63, LDL-C: 0.24-0.58, HDL-C: 0.31-0.57). The bivariate SEMs demonstrated that GLU and HbA1c were correlated with each serum lipid indicator (0.10-0.17), except HDL-C. Except for HbA1c and LDL-C, as well as HbA1c and HDL-C, differences in genetic correlations underlying glycemic traits and serum lipids between age groups were observed, with the youngest group showing a significantly higher genetic correlation than the oldest group. CONCLUSION Across the whole adulthood, genetic influences were consistently important for GLU, TC, TG, LDL-C and HDL-C, and age may affect the shared genetic influences between glycemic traits and serum lipids. Further studies are needed to elucidate the role of age in the interactions of genes related to glycemic traits and serum lipids.
Collapse
Affiliation(s)
- Y Wang
- Department of Epidemiology and Biostatistics, School of Public Health, Peking University, Beijing, China
| | - X Hong
- Department of Epidemiology and Biostatistics, School of Public Health, Peking University, Beijing, China
| | - W Cao
- Department of Epidemiology and Biostatistics, School of Public Health, Peking University, Beijing, China
| | - J Lv
- Department of Epidemiology and Biostatistics, School of Public Health, Peking University, Beijing, China
| | - C Yu
- Department of Epidemiology and Biostatistics, School of Public Health, Peking University, Beijing, China
| | - T Huang
- Department of Epidemiology and Biostatistics, School of Public Health, Peking University, Beijing, China
| | - D Sun
- Department of Epidemiology and Biostatistics, School of Public Health, Peking University, Beijing, China
| | - C Liao
- Department of Epidemiology and Biostatistics, School of Public Health, Peking University, Beijing, China
| | - Y Pang
- Department of Epidemiology and Biostatistics, School of Public Health, Peking University, Beijing, China
| | - Z Pang
- Qingdao Center for Disease Control and Prevention, Qingdao, China
| | - M Yu
- Zhejiang Center for Disease Control and Prevention, Hangzhou, China
| | - H Wang
- Jiangsu Center for Disease Control and Prevention, Nanjing, China
| | - X Wu
- Sichuan Center for Disease Control and Prevention, Chengdu, China
| | - Y Liu
- Heilongjiang Center for Disease Control and Prevention, Harbin, China
| | - W Gao
- Department of Epidemiology and Biostatistics, School of Public Health, Peking University, Beijing, China.
| | - L Li
- Department of Epidemiology and Biostatistics, School of Public Health, Peking University, Beijing, China.
| |
Collapse
|
3
|
Hong X, Li S, Luo R, Yang M, Wu J, Chen S, Zhu S. Mechanisms of the TGF-β1/Smad3-signaling pathway in gender differences in alcoholic liver fibrosis. J Physiol Sci 2024; 74:13. [PMID: 38408944 PMCID: PMC10898046 DOI: 10.1186/s12576-024-00901-y] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 08/18/2023] [Accepted: 01/22/2024] [Indexed: 02/28/2024]
Abstract
The TGF-β1/Smad3-signaling pathway and gender differences were investigated in alcoholic liver fibrosis. Mice were divided into female normal, female model, male normal, and male model groups. Liver injury and fibrosis were assessed using histopathology and serology. Western blotting was performed to analyze the expression of relevant factors. HSC-T6 cells were divided into estradiol + saline, estradiol + ethanol, testosterone + saline, and testosterone + ethanol groups, and similar assessments were conducted in vitro. Compared with the female model group, the male model group exhibited significantly increased GPT, GOT, TNF-α, IL-6, and testosterone levels, fibrosis rate, and TGF-β1, Smad3, and PCNA expression, and significantly decreased estradiol levels and Caspase-3 expression. The apoptosis rate was higher in the estradiol + ethanol group than in the testosterone + ethanol group, although the testosterone + ethanol group exhibited significantly increased TNF-α, IL-6, Collagen-I, α-SMA, TGF-β1, Smad3, and PCNA expression, and significantly decreased Caspase-3 expression. Alcoholic liver fibrosis showed significant gender differences associated with the TGF-β1/Smad3-signaling pathway.
Collapse
Affiliation(s)
- Xiaomin Hong
- The Molecular Medicine Key Laboratory of Liver Injury and Repair, College of Basic Medicine and Forensic Medicine, Henan University of Science and Technology, Luoyang, 471003, People's Republic of China
- Henan Center for Engineering and Technology Research On Prevention and Treatment of Liver Diseases, Luoyang, 471003, People's Republic of China
| | - Sanqiang Li
- The Molecular Medicine Key Laboratory of Liver Injury and Repair, College of Basic Medicine and Forensic Medicine, Henan University of Science and Technology, Luoyang, 471003, People's Republic of China.
- Henan Center for Engineering and Technology Research On Prevention and Treatment of Liver Diseases, Luoyang, 471003, People's Republic of China.
| | - Renli Luo
- The Molecular Medicine Key Laboratory of Liver Injury and Repair, College of Basic Medicine and Forensic Medicine, Henan University of Science and Technology, Luoyang, 471003, People's Republic of China
- Henan Center for Engineering and Technology Research On Prevention and Treatment of Liver Diseases, Luoyang, 471003, People's Republic of China
| | - Mengli Yang
- The Molecular Medicine Key Laboratory of Liver Injury and Repair, College of Basic Medicine and Forensic Medicine, Henan University of Science and Technology, Luoyang, 471003, People's Republic of China
- Henan Center for Engineering and Technology Research On Prevention and Treatment of Liver Diseases, Luoyang, 471003, People's Republic of China
| | - Junfei Wu
- The Molecular Medicine Key Laboratory of Liver Injury and Repair, College of Basic Medicine and Forensic Medicine, Henan University of Science and Technology, Luoyang, 471003, People's Republic of China
- Henan Center for Engineering and Technology Research On Prevention and Treatment of Liver Diseases, Luoyang, 471003, People's Republic of China
| | - Shuning Chen
- Pharmaceutical Science, Monash University, Melbourne, Australia
| | - Siyu Zhu
- The Molecular Medicine Key Laboratory of Liver Injury and Repair, College of Basic Medicine and Forensic Medicine, Henan University of Science and Technology, Luoyang, 471003, People's Republic of China
- Henan Center for Engineering and Technology Research On Prevention and Treatment of Liver Diseases, Luoyang, 471003, People's Republic of China
| |
Collapse
|
4
|
Hong X, Zhang Y, Chi Z, Xu Q, Lin W, Huang Y, Lin T, Zhang Y. Efficacy and Safety of Programmed Death-1 (PD-1)/Programmed Death-Ligand 1 (PD-L1) Checkpoint Inhibitors in Patients With Metastatic Castration-resistant Prostate Cancer: A Systematic Review and Meta-analysis. Clin Oncol (R Coll Radiol) 2024; 36:e20-e30. [PMID: 37993317 DOI: 10.1016/j.clon.2023.11.034] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 02/17/2023] [Revised: 09/14/2023] [Accepted: 11/13/2023] [Indexed: 11/24/2023]
Abstract
AIMS The aim of this systematic review with meta-analysis was to evaluate the efficacy and safety of programmed death-1 (PD-1)/programmed death-ligand 1 (PD-L1) checkpoint inhibitors in patients with metastatic castration-resistant prostate cancer (mCRPC). MATERIALS AND METHODS We searched PubMed, Embase and Cochrane Library until 1 July 2022 for mCRPC trials testing PD-1/PD-L1 checkpoint inhibitors. We measured the efficacy and safety using overall survival, progression-free survival (PFS), overall response rates (ORR), prostate-specific antigen (PSA) response rate or treatment-related adverse events (TRAEs). When possible, data were meta-analysed. RESULTS Thirteen studies involving 2533 participants were included in this meta-analysis. The pooled hazard ratio for overall survival was 0.81 (95% confidence interval 0.42-1.20, I2 = 80.3%, PHeterogeneity<0.001) and for PFS was 0.65 (95% confidence interval 0.38-0.92, I2 = 72.2%, PHeterogeneity = 0.013). Furthermore, better ORR (relative risk = 2.77, 95% confidence interval 1.25-6.13, I2 = 0%, PHeterogeneity = 0.699) was found in PD-L1-expressing tumours. However, no statistical trends between PD-L1 status on PSA response rate (relative risk = 0.79, 95% confidence interval 0.5-1.25, I2 = 0%, PHeterogeneity = 0.953) and tumour mutational burden on ORR (relative risk = 2.53, 95% confidence interval 0.49-13.12, I2 = 74.5%, PHeterogeneity = 0.02) were observed. The pooled proportions of TRAEs and ≥ grade 3 TRAEs were 85.1% (95% confidence interval = 71.7-98.5%) and 31.6% (95% confidence interval = 18.9-44.4%), respectively. CONCLUSIONS This meta-analysis showed that among selected populations of men with mCRPC, anti-PD-1/PD-L1 combination treatment may significantly increase the PFS benefits. However, overall survival in mCRPC warrants further testing.
Collapse
Affiliation(s)
- X Hong
- Department of Urology, Sun Yat-sen Memorial Hospital, Sun Yat-sen University, Guangzhou, PR China; Department of Urology, Shantou Central Hospital, Shantou, PR China
| | - Y Zhang
- Department of Urology, Shantou Central Hospital, Shantou, PR China
| | - Z Chi
- Department of Urology, Shantou Central Hospital, Shantou, PR China
| | - Q Xu
- Department of Urology, Shantou Central Hospital, Shantou, PR China
| | - W Lin
- Department of Urology, Shantou Central Hospital, Shantou, PR China
| | - Y Huang
- Department of Urology, Shantou Central Hospital, Shantou, PR China
| | - T Lin
- Department of Urology, Sun Yat-sen Memorial Hospital, Sun Yat-sen University, Guangzhou, PR China.
| | - Y Zhang
- Department of Urology, Shantou Central Hospital, Shantou, PR China.
| |
Collapse
|
5
|
Zhang J, Peng G, Ding Q, Qin Y, Wu B, Zhang Z, Zou Z, Shi L, Hong X, Han J, Liang Z, Yang K, Huang J. Standard Therapy vs. Individualized Therapy in Elderly Locally Advanced Nasopharyngeal Carcinoma: A Real-World Study. Int J Radiat Oncol Biol Phys 2023; 117:e589. [PMID: 37785782 DOI: 10.1016/j.ijrobp.2023.06.1937] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/04/2023]
Abstract
PURPOSE/OBJECTIVE(S) Concurrent chemoradiotherapy (CRT) with/without induction chemotherapy has been the standard therapy (ST) for locally advanced nasopharyngeal carcinoma (LA-NPC). However, most patients supporting these clinical trials were younger than 65 years of age. For the toxicity of CRT and the poor tolerance of elderly patients, it is still controversial whether ST could bring the most promising survival benefits for elderly NPC compared with individualized therapy (IT). Thus, in this real-world study we compared the survival and safety of ST with IT in elderly LA-NPC to explore an effective and tolerable treatment strategy for elderly LA-NPC. MATERIALS/METHODS A total of 109 newly diagnosed elderly LA-NPC (>65 years old) from Jan. 2013-Jul. 2020 were retrospectively enrolled and divided into the ST group and IT group according to the original treatment tendency. ST refers to CRT with/without induction chemotherapy. IT group included patients not suitable for CRT and were given individualized treatment fully discussed by at least two oncologists from our head and neck team. A 1:1 propensity score matching (PSM) generated a matched cohort of ST and IT. The survivals and treatment related toxicities were compared between the two groups. RESULTS There were 46 cases in the ST group and 63 cases in the IT group. The 5-year overall survival (OS) rate, cancer-specific survival (CSS) rate, progression- free survival (PFS) rate, local recurrence-free survival (LRFS) rate and distant metastasis-free survival (DMFS) rate were 68.64%, 76.42%, 73.69%, 85.67% and 86.82%, respectively. By 1:1PSM, 35 cases in each group were matched. No significant differences of OS, CSS, PFS, LRFS and DMFS were found between ST and IT groups in the PSM-matched cohorts (P = 0.87, P = 0.79, P = 0.51, P = 0.81 and P = 0.24, respectively). Compared with patients in the ST group, cases received IT were associated with less severe acute toxicities including anemia, leucopenia, neutropenia, and thrombocytopenia. CONCLUSION For elderly LA-NPC, IT had similar survivals while less severe toxicities compared with ST, which revolutionarily challenged the role of ST for elderly LA-NPC. In the future, more studies are need to explore a less toxic treatment modality with noninferior efficacy for elderly LA-NPC.
Collapse
Affiliation(s)
- J Zhang
- Cancer Center, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China
| | - G Peng
- Cancer Center, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China
| | - Q Ding
- Cancer Center, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China
| | - Y Qin
- Cancer Center, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China
| | - B Wu
- Cancer Center, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China
| | - Z Zhang
- Cancer Center, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China
| | - Z Zou
- Cancer Center, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China
| | - L Shi
- Cancer Center, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China
| | - X Hong
- Cancer Center, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China
| | - J Han
- Cancer Center, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China
| | - Z Liang
- Cancer Center, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China
| | - K Yang
- Cancer Center, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China
| | - J Huang
- Cancer Center, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China
| |
Collapse
|
6
|
Garrison-Desany HM, Ladd-Acosta C, Hong X, Wang G, Burd I, Sanchez ZM, Wang X, Surkan PJ. Addressing the Smoking-Hypertension Paradox in Pregnancy: Insight from a Multiethnic US Birth Cohort. Precis Nutr 2023; 2:e00035. [PMID: 37398892 PMCID: PMC10312115] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Grants] [Subscribe] [Scholar Register] [Indexed: 07/04/2023]
Abstract
Background Smoking during pregnancy has been associated with reduced risk of a spectrum of hypertensive (HTN) disorders, known as the "smoking-hypertension paradox." Objective We sought to test potential epidemiologic explanations for the smoking-hypertension paradox. Methods We analyzed 8,510 pregnant people in the Boston Birth Cohort, including 4,027 non-Hispanic Black and 2,428 Hispanic pregnancies. Study participants self-reported tobacco, alcohol, cannabis, opioids, or cocaine use during pregnancy. We used logistic regression to assess effect modification by race/ethnicity, and confounding of concurrent substances on hypertensive disorders or prior pregnancy. We also investigated early gestational age as a collider or competing risk for pre-eclampsia, using cause-specific Cox models and Fine-Gray models, respectively. Results We replicated the paradox showing smoking to be protective against hypertensive disorders among Black participants who used other substances as well (aOR: 0.61, 95% CI: 0.41, 0.93), but observed null effects for Hispanic participants (aOR: 1.14, 95% CI: 0.55, 2.36). In our cause-specific Cox regression, the effects of tobacco use were reduced to null effects with pre-eclampsia (aOR: 0.81, 95% CI: 0.63, 1.04) after stratifying for preterm birth. For the Fine-Gray competing risk analysis, the paradoxical associations remained. The smoking paradox was either not observed or reversed after accounting for race/ethnicity, other substance use, and collider-stratification due to preterm birth. Conclusions These findings offer new insights into this paradox and underscore the importance of considering multiple sources of bias in assessing the smoking-hypertension association in pregnancy.
Collapse
Affiliation(s)
| | - C Ladd-Acosta
- Department of Epidemiology, Johns Hopkins Bloomberg School of Public Health
| | - X Hong
- Center on the Early Life Origins of Disease, Department of Population, Family and Reproductive Health, Johns Hopkins University Bloomberg School of Public Health
| | - G Wang
- Center on the Early Life Origins of Disease, Department of Population, Family and Reproductive Health, Johns Hopkins University Bloomberg School of Public Health
| | - I Burd
- Integrated Research Center for Fetal Medicine, Department of Gynecology and Obstetrics, Johns Hopkins University School of Medicine, Baltimore, Maryland, USA
| | - Z M Sanchez
- Escola Paulista de Medicina, Universidade Federal de São Paulo
| | - X Wang
- Center on the Early Life Origins of Disease, Department of Population, Family and Reproductive Health, Johns Hopkins University Bloomberg School of Public Health
- Department of Pediatrics, Johns Hopkins University School of Medicine, Baltimore, Maryland, USA
| | - P J Surkan
- Center on the Early Life Origins of Disease, Department of Population, Family and Reproductive Health, Johns Hopkins University Bloomberg School of Public Health
- Department of International Health, Johns Hopkins Bloomberg School of Public Health
| |
Collapse
|
7
|
Wen W, Li H, Wang C, Chen C, Tang J, Zhou M, Hong X, Cheng Y, Wu Q, Zhang X, Feng Z, Wang M. Efficacy and safety of outpatient parenteral antibiotic therapy in patients with infective endocarditis: a meta-analysis. Rev Esp Quimioter 2022; 35:370-377. [PMID: 35652306 PMCID: PMC9333124 DOI: 10.37201/req/011.2022] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.5] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Subscribe] [Scholar Register] [Indexed: 12/12/2022]
Abstract
OBJECTIVE To investigate the clinical outcome of patients with infective endocarditis (IE) during and after outpatient parenteral antimicrobial treatment (OPAT), and to further clarify the safety and efficacy of OPAT for IE patients. METHODS Through December 20, 2021, a total of 331 articles were preliminarily searched in Pubmed, Web of Science, Cochrane Library and Embase, and 9 articles were eventually included in this study. RESULTS A total of 9 articles comprising 1,116 patients were included in this study. The overall mortality rate of patients treated with OPAT was 0.04 (95% CI, 0.02-0.07), that means 4 deaths per 100 patients treated with OPAT. Separately, mortality was low during the follow-up period after OPAT treatment, with an effect size (ES) of 0.03 (95%CI, 0.02-0.07) and the mortality of patients during OPAT treatment was 0.04 (95% CI, 0.01-0.12). In addition, the readmission rate was found to be 0.14 (95% CI, 0.09-0.22) during the follow-up and 0.18 (95% CI, 0.08-0.39) during treatment, and 0.16 (95% CI, 0.10-0.24) for patients treated with OPAT in general. Regarding the relapse of IE in patients, our results showed a low overall relapse rate, with an ES of 0.03 (95% CI, 0.01-0.05). In addition, we found that the incidence of adverse events was low, with an ES of 0.26 (95% CI, 0.19-0.33). CONCLUSIONS In general, the incidence of adverse events and mortality, readmission, and relapse rates in IE patients treated with OPAT are low both during treatment and follow-up period after discharge, indicating that OPAT is safe and effective for IE patients. However, our study did not compare routine hospitalization as a control group, so conclusions should be drawn with caution. In order to obtain more scientific and rigorous conclusions and reduce clinical risks, it is still necessary to conduct more research in this field and improve the patient selection criteria for OPAT treatment, especially for IE patients. Finally, clinical monitoring and follow-up of OPAT-treated patients should be strengthened.
Collapse
Affiliation(s)
| | | | | | | | | | | | | | | | | | | | | | - M Wang
- Mingwei Wang, MD, PhD, Hangzhou Institute of Cardiovascular Diseases, Affiliated Hospital of Hangzhou Normal University, Hangzhou Normal University, Hangzhou, 310015, China.
| |
Collapse
|
8
|
Matei AE, Markéta K, Xu L, Györfi AH, Boxberger E, Soteriou D, Papava M, Prater J, Hong X, Kräter M, Schett G, Guck J, Distler JHW. POS0883 BIOPHYSICAL PROPERTIES OF MONOCYTES INDICATE DISEASE ACTIVITY, SEVERITY OF FIBROTIC OR MICROVASCULAR MANIFESTATIONS AND THE RISK FOR PROGRESSION IN SYSTEMIC SCLEROSIS. Ann Rheum Dis 2022. [DOI: 10.1136/annrheumdis-2022-eular.2785] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/04/2022]
Abstract
BackgroundDysregulated immune responses are major pathogenic players in systemic sclerosis (SSc). The biophysical properties (such as cell deformation, Young’s modulus (a measure of cell stiffness) and area) of circulating immune cells reflect their states and functions, as well as their pathological activation (1-3). Thus, biophysical phenotyping can provide access to a novel, mostly unexplored layer of information that is currently not accessible with standard techniques of cellular and molecular biology. Real-time fluorescence and deformability cytometry (RT-FDC) is a novel technique that enables biophysical phenotyping of individual immune cells at a high throughput, which allows its use in a clinical setting (3-5).ObjectivesHere, we hypothesized that biophysical properties of circulating immune cells in SSc and rheumatoid arthritis (RA) might specifically reflect their distinct pathophysiological activation in the respective disease, and might indicate clinical outcomes such as disease activity or severity. We thus performed RT-FDC-based biophysical phenotyping of circulating immune cells in SSc, RA and healthy controls.Methods63 SSc patients, 59 RA patients fulfilling the respective ACR/EULAR classification criteria and 18 age- and sex-matched healthy controls were included in the study between 05.2019 and 09.2021. Peripheral blood mononuclear cells (PBMC) were isolated and immunolabelled. PBMC subpopulations were identified in RT-FDC by standard gating strategies based on their marker expression and their deformation, Young’s modulus and area were determined.ResultsWe identified SSc-specific changes (changes in SSc, but not in RA compared to healthy controls) in the biophysical properties of NK, NKT-like cells and monocyte subpopulations in SSc. Monocytes subpopulations had a higher deformation and cross-sectional area and/or more compact intra-donor distributions of these parameters in patients with active disease and with extensive skin or lung fibrosis in comparison with patients with stable disease and limited skin or lung fibrosis, respectively. All monocytes subsets were stiffer in patients with progression of skin of lung fibrosis at the time of measurement in comparison with a previous visit. The deformation and area of intermediate monocytes could also identify patients at risk for future progression of lung fibrosis. Changes in biophysical properties of monocytes can indicate, beyond fibrotic burden, clinical manifestations of microvascular damage such as active digital ulcers and pulmonary arterial hypertension.ConclusionWe demonstrated that changes in the biophysical properties of monocytes subsets are associated with multiple clinical outcomes in SSc such as disease activity, severity of fibrotic or microvascular manifestations and risk of progression and might thus directly reflect SSc-specific pathologic immune cell activation. Our results thus provide first evidence that RT-FDC-based biophysical phenotyping of circulating immune cells may be a useful tool for clinical evaluation of SSc patients.References[1]Bashant KR, Toepfner N, Day CJ, Mehta NN, Kaplan MJ, Summers C, et al. The mechanics of myeloid cells. Biol Cell. 2020;112(4):103-12.[2]Toepfner N, Herold C, Otto O, Rosendahl P, Jacobi A, Krater M, et al. Detection of human disease conditions by single-cell morpho-rheological phenotyping of blood. Elife. 2018;7.[3]Kubankova M, Hohberger B, Hoffmanns J, Furst J, Herrmann M, Guck J, et al. Physical phenotype of blood cells is altered in COVID-19. Biophys J. 2021;120(14):2838-47.[4]Otto O, Rosendahl P, Mietke A, Golfier S, Herold C, Klaue D, et al. Real-time deformability cytometry: on-the-fly cell mechanical phenotyping. Nat Methods. 2015;12(3):199-202, 4 p following[5]Rosendahl P, Plak K, Jacobi A, Kraeter M, Toepfner N, Otto O, et al. Real-time fluorescence and deformability cytometry. Nat Methods. 2018;15(5):355-8.Disclosure of InterestsAlexandru-Emil Matei: None declared, Kubánková Markéta: None declared, Liyan Xu: None declared, Andrea-Hermina Györfi: None declared, Evgenia Boxberger: None declared, Despina Soteriou: None declared, Maria Papava: None declared, Julia Prater: None declared, Xuezhi Hong: None declared, Martin Kräter: None declared, Georg Schett: None declared, Jochen Guck: None declared, Jörg H.W. Distler Shareholder of: JHWD is stock owner of 4D Science., Consultant of: JHWD has consultancy relationships with Actelion, Active Biotech, Anamar, Bayer Pharma, Boehringer Ingelheim, Celgene, Galapagos, GSK, Inventiva, JB Therapeutics, Medac, Pfizer, RuiYi and UCB, Grant/research support from: JHWD has received research funding from Anamar, Active Biotech, Array Biopharma, aTyr, BMS, Bayer Pharma, Boehringer Ingelheim, Celgene, Galapagos, GSK, Inventiva, Novartis, Sanofi-Aventis, RedX, UCB
Collapse
|
9
|
Yang K, Zhang X, Zhang Z, Wu B, Peng G, Huang J, Ding Q, Xiao G, Ma H, Yang C, Xiong X, Shi L, Yang J, Hong X, Wei J, Qin Y, Zhong Y, Zhou Y, Zhao X, Leng Y. 145P Neoadjuvant chemotherapy combined with camrelizumab for locally advanced head and neck squamous cell carcinoma: A phase II trial. Ann Oncol 2021. [DOI: 10.1016/j.annonc.2021.10.164] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/01/2022] Open
|
10
|
Liu X, Wu B, Huang J, Ding Q, Qin Y, Hong X, Shi L, Zhang Z, Peng G, Yang K. Patterns of Local-Regional Relapse Following Intensity-Modulated Radiotherapy for Patients With Nasopharyngeal Carcinoma. Int J Radiat Oncol Biol Phys 2021. [DOI: 10.1016/j.ijrobp.2021.07.1132] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/26/2022]
|
11
|
Hong X, Zhao J, Zhu X, Dai Q, Zhang H, Xuan Y, Yin J, Zhang Y, Yang X, Fang S, Wang Q, Shen H, Zhang Y, Yan D, Wang Y, Peng Z, Zhang Y, Wang B, Ma X. The association between the vaginal microenvironment and fecundability: a register-based cohort study among Chinese women. BJOG 2021; 129:43-51. [PMID: 34258836 DOI: 10.1111/1471-0528.16843] [Citation(s) in RCA: 3] [Impact Index Per Article: 1.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 08/28/2020] [Revised: 05/18/2021] [Accepted: 05/27/2021] [Indexed: 12/13/2022]
Abstract
OBJECTIVE To evaluate the association between the vaginal microenvironment and fecundability among women. DESIGN Register-based nationwide cohort study. SETTING Chinese National Free Pre-conception Check-up Project from 2015 to 2018. POPULATION Our study included a total of 3 388 554 eligible women who were attempting to become pregnant. METHOD We assessed the vaginal microenvironment at baseline by considering four indices: vaginal pH, clue cell examination, whiff test and vaginal cleanliness grading. If any of these indicators was abnormal, the vaginal microenvironment was defined as poor. Propensity score matching was used to control for potential confounders and reduce bias. Logistic models were used to estimate the fecundability odds ratios (FORs) after adjustment for covariates. MAIN OUTCOME MEASURES Achievement of a pregnancy within 1 year. RESULTS Of the total study population, 379 718 women (11.2%) had a poor vaginal microenvironment and their pregnancy rate after 1 year was significantly lower than the group with a normal microenvironment (71.8% versus 76.1%, P < 0.001). After adjusting for potential confounders, the women with a poor vaginal microenvironment were associated with a 9% reduction in fecundability compared with the normal microenvironment group (FOR 0.91, 95% CI 0.90-0.92). The adverse effects of a poor vaginal microenvironment were stronger among multipara (FOR 0.89, 95% CI 0.87-0.90) or women with irregular menstruation (FOR 0.86, 95% CI 0.84-0.89). CONCLUSION There was a negative association between a poor vaginal microenvironment and the fecundability of women. These findings highlight the significance of assessing the vaginal microenvironment during pre-pregnancy health examinations. TWEETABLE ABSTRACT Women with a poor vaginal microenvironment were associated with a reduction in fecundability.
Collapse
Affiliation(s)
- X Hong
- Key Laboratory of Environmental Medicine and Engineering of Ministry of Education, Department of Epidemiology and Health Statistics, School of Public Health, Southeast University, Nanjing, Jiangsu, China
| | - J Zhao
- National Research Institute for Family Planning, Beijing, China.,National Human Genetic Resources Centre, Beijing, China
| | - X Zhu
- Key Laboratory of Environmental Medicine and Engineering of Ministry of Education, Department of Epidemiology and Health Statistics, School of Public Health, Southeast University, Nanjing, Jiangsu, China
| | - Q Dai
- National Research Institute for Family Planning, Beijing, China.,National Human Genetic Resources Centre, Beijing, China
| | - H Zhang
- National Research Institute for Family Planning, Beijing, China.,National Human Genetic Resources Centre, Beijing, China
| | - Y Xuan
- Key Laboratory of Environmental Medicine and Engineering of Ministry of Education, Department of Epidemiology and Health Statistics, School of Public Health, Southeast University, Nanjing, Jiangsu, China
| | - J Yin
- Key Laboratory of Environmental Medicine and Engineering of Ministry of Education, Department of Epidemiology and Health Statistics, School of Public Health, Southeast University, Nanjing, Jiangsu, China
| | - Yue Zhang
- National Research Institute for Family Planning, Beijing, China.,National Human Genetic Resources Centre, Beijing, China
| | - X Yang
- National Research Institute for Family Planning, Beijing, China.,National Human Genetic Resources Centre, Beijing, China
| | - S Fang
- The Mount Sinai Health System, New York, NY, USA
| | - Q Wang
- Department of Maternal and Child Health, National Health Commission of the People's Republic of China, Beijing, China
| | - H Shen
- Department of Maternal and Child Health, National Health Commission of the People's Republic of China, Beijing, China
| | - Yiping Zhang
- Department of Maternal and Child Health, National Health Commission of the People's Republic of China, Beijing, China
| | - D Yan
- Department of Maternal and Child Health, National Health Commission of the People's Republic of China, Beijing, China
| | - Y Wang
- National Research Institute for Family Planning, Beijing, China.,National Human Genetic Resources Centre, Beijing, China
| | - Z Peng
- National Research Institute for Family Planning, Beijing, China.,National Human Genetic Resources Centre, Beijing, China
| | - Ya Zhang
- National Research Institute for Family Planning, Beijing, China.,National Human Genetic Resources Centre, Beijing, China
| | - B Wang
- Key Laboratory of Environmental Medicine and Engineering of Ministry of Education, Department of Epidemiology and Health Statistics, School of Public Health, Southeast University, Nanjing, Jiangsu, China
| | - X Ma
- National Research Institute for Family Planning, Beijing, China.,National Human Genetic Resources Centre, Beijing, China
| |
Collapse
|
12
|
Chen Y, Hong X, Liu L, Zhan Z, Li X, Pu C, Chen S, Liao S. [Anatomy of the deep circumflex iliac artery perforators and reconstruction of complex mandibular defects with chimeric deep circumflex iliac artery perforator flap]. Nan Fang Yi Ke Da Xue Xue Bao 2021; 41:754-759. [PMID: 34134964 DOI: 10.12122/j.issn.1673-4254.2021.05.17] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Subscribe] [Scholar Register] [Indexed: 11/24/2022]
Abstract
OBJECTIVE To investigate the anatomy of the perforator vessels of the deep circumflex iliac artery (DCIA) and the techniques for repairing mandibular complex defect using chimeric deep circumflex iliac artery perforator flap (DCIAPF). OBJECTIVE We analyzed the origin, distribution, number and courses of the perforator vessels of the DCIA, and measured the outside diameters of the vessels at the origin in 6 adult cadaveric specimens (12 sides) with latex perfusion. From July, 2018 to September, 2019, based on the results of anatomical study and imaging findings and using the digital surgical guide plate, we harvested DCIAPF from 4 patients for repairing mandibular body or angle defects and oral soft tissue defects. OBJECTIVE The perforating vessels of the DCIA included abdominal muscular branches, osteomusculocutaneous branches and terminal musculocutaneous branches. The abdominal muscle branches originated from the DCIA inguinal segment in 4 and from both the inguinal and iliac segments in 2 of the specimens. The osteomusculocutaneous branches all originated from the internal iliac crest in 75% and from both the inguinal and internal iliac crest segments in 25% of cases; the inguinal segment gave rise to only one perforating branch. The number of the musculocutaneous perforating branches was 1 (58.3%) or 2 (41.7%). In the 4 patients undergoing mandibular reconstruction, the DCIAPF survived in all cases with good recovery of the donor site wound. Satisfactory facial appearance with good oral morphology and occlusal relationship was achieved at 1 month postoperatively in all the patients. None of the patients experienced obvious functional abnormalities at the donor site, and imaging examination confirmed successful reconstruction of the oromandibular defects in all the cases. OBJECTIVE A good understanding of the anatomic characteristics of the perforator vessels of the DCIA combined with imaging examinations and digital surgery technology facilitates the harvest of DCIAPF for repairing mandibular body or angle defects complicated by oral soft tissue defects.
Collapse
Affiliation(s)
- Y Chen
- Department of Stomatology, First Affiliated Hospital of Bengbu Medical College, Bengbu 233004, China
| | - X Hong
- Department of Stomatology, First Affiliated Hospital of Bengbu Medical College, Bengbu 233004, China
| | - L Liu
- Department of Stomatology, First Affiliated Hospital of Bengbu Medical College, Bengbu 233004, China
| | - Z Zhan
- Department of Stomatology, First Affiliated Hospital of Bengbu Medical College, Bengbu 233004, China
| | - X Li
- Department of Stomatology, First Affiliated Hospital of Bengbu Medical College, Bengbu 233004, China
| | - C Pu
- Department of Ultrasonic Medicine, First Affiliated Hospital of Bengbu Medical College, Bengbu 233004, China
| | - S Chen
- Department of Anatomy, Bengbu Medical College, Bengbu 233030, China
| | - S Liao
- Department of Stomatology, First Affiliated Hospital of Bengbu Medical College, Bengbu 233004, China
| |
Collapse
|
13
|
Györfi AH, Matei AE, Fuchs M, Rius Rigau A, Hong X, Honglin Z, Luber M, Bergmann C, Dees C, Ludolph I, Horch R, Distler O, Schett G, Kunz M, Distler JHW. POS0328 ENGRAILED 1 COORDINATES CYTOSKELETAL ORGANIZATION TO PROMOTE MYOFIBROBLAST DIFFERENTIATION AND FIBROTIC TISSUE REMODELING. Ann Rheum Dis 2021. [DOI: 10.1136/annrheumdis-2021-eular.1428] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/03/2022]
Abstract
Background:Engrailed 1 (EN1) is a homeodomain-containing transcription factor with essential roles in embryonic development. In most cell types, the expression of EN1 is restricted to embryonic development. However, under pathological conditions, EN1 can be re-expressed to promote phenotypical adaptation. En1 is transiently expressed in the developing dermis of murine embryos in a distinct fibroblast lineage and silenced before birth (1). Former EN1-expressing cells give rise to a subpopulation of fibroblasts that has a high capacity for extracellular matrix production in adult murine skin. The role of EN1 in systemic sclerosis (SSc) was previously not explored.Objectives:To study the role of EN1 in the pathological activation of fibroblasts in tissue fibrosis.Methods:Bulk RNA-Seq and EN1 or SP1 ChIP-Seq were performed from cultured human dermal fibroblasts. The expression of EN1 was inhibited by siRNA. Cytoskeletal drugs paclitaxel, vinblastin and ROCK inhibitor (Y27632) were used to modulate the cytoskeleton in EN1 knockdown or overexpressing dermal fibroblasts. The role of EN1 in fibroblast activation was evaluated by functional experiments with EN1 knockdown or overexpression in standard 2D culture systems as well as in 3D skin equivalent models. The role of EN1 in skin fibrosis was further studied in En1fl/fl X Col6Cre mice, with fibroblast-specific knockout of En1 in three complementary mouse models: overexpression of a constitutively active TGFß-receptor I (TBRICA), bleomycin-induced skin fibrosis and TSK1 mice.Results:Pathologically activated dermal fibroblasts from SSc patients express higher levels of EN1 compared with age and sex matched healthy individuals in the skin and in vitro. TGFβ induces EN1 expression in fibroblasts in a SMAD3-dependent manner both in cultured fibroblasts and in murine skin. Knockdown of EN1 prevents TGFβ-induced fibroblast activation, whereas overexpression of EN1 fosters the pro-fibrotic effects of TGFβ with increased expression of αSMA, stress fibers and collagen. RNA sequencing demonstrates that EN1 induces a pro-fibrotic gene expression profile functionally related to cytoskeleton organization and ROCK activation. In silico analyses of the promoters of En1 target genes coupled with siRNA-mediated knockdown demonstrated that EN1 regulates these pro-fibrotic target genes by modulating the activity of regulatory modules that contain transcription factors of the specificity protein (SP) family. Functional experiments with selective modulators of ROCK and of microtubule polymerization confirm the coordinating role of EN1 on ROCK activity and the re-organization of cytoskeleton during myofibroblast differentiation in both conventional culture systems and 3D skin equivalents. Consistently, mice with fibroblast-specific knockout of En1 demonstrate impaired fibroblast-to-myofibroblast transition, reduced dermal thickening and impaired collagen deposition in the TBRICA, bleomycin-induced and TSK1 models.Conclusion:We characterize the homeodomain transcription factor EN1 as a molecular amplifier of TGFβ signaling in myofibroblast differentiation that coordinates cytoskeletal organization in a SP-dependent manner. EN1 might thus be a novel candidate for molecular targeted therapies to interfere with myofibroblast differentiation in fibrotic diseases.References:[1]Rinkevich Y, Walmsley GG, Hu MS, Maan ZN, Newman AM, Drukker M, et al. Skin fibrosis. Identification and isolation of a dermal lineage with intrinsic fibrogenic potential. Science. 2015;348(6232):aaa2151.Disclosure of Interests:Andrea-Hermina Györfi: None declared, Alexandru-Emil Matei: None declared, Maximilian Fuchs: None declared, Aleix Rius Rigau: None declared, Xuezhi Hong: None declared, ZHU Honglin: None declared, Markus Luber: None declared, Christina Bergmann: None declared, Clara Dees: None declared, Ingo Ludolph: None declared, Raymund Horch: None declared, Oliver Distler Consultant of: Actellion, AbbVie, Acceleron Pharma, Anamar, Amgen, Blade Therapeutics, CSL Behring, ChemomAb, Ergonex, Glenmark Pharma, GSK, Inventiva, Italfarmaco, iQvia, Medac, Medscape, Lilly, Sanofi, Target BioScience, UCB, Bayer, Boehringer Ingelheim, Catenion, iQone, Menarini, Mepha, Novartis, Mitsubishi, MSD, Roche, Pfizer, Georg Schett: None declared, Meik Kunz: None declared, Jörg H.W. Distler Consultant of: Actelion, Active Biotech, Anamar, ARXX, Bayer Pharma, Boehringer Ingelheim, Celgene, Galapagos, GSK, Inventiva, JB Therapeutics, Medac, Pfizer, RuiYi and UCB., Grant/research support from: Anamar, Active Biotech, Array Biopharma, aTyr, BMS, Bayer Pharma, Boehringer Ingelheim, Celgene, Galapagos, GSK, Inventiva, Novartis, Sanofi-Aventis, RedX, UCB
Collapse
|
14
|
Li F, Hong X, Jiang J. [Calpain activation promotes dialysis-associated peritoneal fibrosis in rats]. Nan Fang Yi Ke Da Xue Xue Bao 2021; 41:593-599. [PMID: 33963721 DOI: 10.12122/j.issn.1673-4254.2021.04.17] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Subscribe] [Scholar Register] [Indexed: 11/24/2022]
Abstract
OBJECTIVE To explore the role of calpain activation in the progression of peritoneal fibrosis. OBJECTIVE Twenty-four male Sprague-Dawley rats were randomized equally into control group, MDL28170 (a calpain inhibitor)+normal saline group, peritoneal dialysis (PD) model group and PD + MDL28170 group. In the latter two groups, the rats received daily intraperitoneal injections of 100 mL/kg of 4.25% glucose PD solution, and those in PD+MDL28170 group and MDL28170 saline group received daily infusion of 4 mg/kg MDL28170 every other day. Eight weeks later, the rats were euthanized for pathological examination of the parietal peritoneum, and the visceral peritoneum was used for examining the activation status of calpain and the expressions of fibronectin (FN) and collagen I (COL-I). Calpain activation and expressions of FN, COL-I and α-SMA were also examined using Western blotting and immunofluorescence assay in primary cultures of rat peritoneal mesothelial cells treated with MDL28170, transforming growth factor-β (TGF-β), or both. OBJECTIVE Compared with the control rats, the rats in PD model group showed significantly increased peritoneal peritoneum thickness, calpain activation in the peritoneal tissue, and expressions of FN and COL-I (P < 0.05). Treatment with MDL28170 significantly alleviated associated peritoneal fibrosis, decreased the thickness of the peritoneum (P < 0.05), and reduced the expressions of FN and COL-I in the rats with daily PD (P < 0.05). In the in vitro experiment, the expressions of FN and COL-I were also significantly lower in rat peritoneal mesothelial cells treated with both MDL28170 and TGF-β than in the cells treated with TGF-β alone (P < 0.05). OBJECTIVE Peritoneal calpain activity and expressions FN and COL-I all increase significantly in rat models of PD-associated peritoneal fibrosis. Calpain activation can promote peritoneal fibrosis, and inhibition of calpain can alleviate peritoneal fibrosis.
Collapse
Affiliation(s)
- F Li
- Department of Nephrology, Nanfang Hospital, Southern Medical University, Guangzhou 510515, China
| | - X Hong
- Department of Nephrology, Nanfang Hospital, Southern Medical University, Guangzhou 510515, China
| | - J Jiang
- Department of Nephrology, Nanfang Hospital, Southern Medical University, Guangzhou 510515, China
| |
Collapse
|
15
|
Zhao HM, Jin L, Liu Y, Hong X. Changes in expressions of miR-22-3p and MMP-9 in rats with thoracic aortic aneurysm and their significance. Eur Rev Med Pharmacol Sci 2021; 24:6949-6954. [PMID: 32633388 DOI: 10.26355/eurrev_202006_21686] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Subscribe] [Scholar Register] [Indexed: 11/12/2022]
Abstract
OBJECTIVE The purpose of this study was to explore the changes in the expressions of micro ribonucleic acid (miR)-22-3p and matrix metalloproteinase-9 (MMP-9) in rats with thoracic aortic aneurysm (TAA) and their significance. MATERIALS AND METHODS A total of 16 specific pathogen-free Sprague-Dawley female rats were randomly divided into normal group (n=8) and angiotensin II (Ang II) group (n=8). Ang II was perfused using the micro pump in Ang II group, while the same amount of normal saline was perfused in the normal group. After continuous intervention, the tumor formation rate in the thoracic aorta was observed, and the expression of miR-22-3p was detected via Reverse Transcription-Polymerase Chain Reaction (RT-PCR) in both groups. Other 16 rats were selected and randomly divided into agomiR-22-3p group (n=8) and control group (n=8). In the agomiR-22-3p group, agomiR-22 and Ang II were continuously injected via angular vein. In the control group, agomiR negative control was injected, and Ang II was continuously perfused. After intervention for 4 weeks, the tumor formation rate in the thoracic aorta was observed, and the expression of MMP-9 was determined via immunofluorescence and immunohistochemistry in both groups. RESULTS After intervention for 4 weeks, the expression of miR-22-3p in Ang II group was significantly lower than that in normal group (p<0.05). After drug administration for 4 weeks, agomiR-22-3p group had a lower tumor formation rate (p<0.05) and a lower expression of MMP-9 than the control group (p<0.05). CONCLUSIONS The expression of miR-22-3p declines in TAA rats, and miR-22-3p can inhibit the expression of MMP-9, thus suppressing the formation of TAA in rats.
Collapse
Affiliation(s)
- H-M Zhao
- Department of Vascular Surgery, China-Japan Union Hospital of Jilin University, Changchun, China.
| | | | | | | |
Collapse
|
16
|
Hong X, Yin JC, Wang B. [Probe variables: a tool for identification of unmeasured confounders in an observational study]. Zhonghua Liu Xing Bing Xue Za Zhi 2021; 42:735-739. [PMID: 34814460 DOI: 10.3760/cma.j.cn112338-20200315-00355] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Subscribe] [Scholar Register] [Indexed: 06/13/2023]
Abstract
There are usually unknown or unmeasured confounders in the observational study, which is a significant challenge in epidemiological causal association research. This paper presents a tool for identification and effect assessment of unknown/unmeasured confounders in observational studies: probe variables. It can be divided into three forms: exposure probe variable, outcome probe variable, and mediation probe variable. The first two types can identify unknown/unmeasured confounding factors and estimate their size of effect to reveal the real correlation between exposure and outcome. The mediation probe variable controls for "mediating factors" to identify unmeasured confounders between exposure and results. The most significant difficulty in this theory's practice is selecting and determining "probe variables." Improper probe variables may introduce unknown confounders, which may lead to false identification of unmeasured confounders. Probe variables can be recommended as a sensitivity analysis in observational studies to help readers truly understand the association between exposure and outcomes and to increase the strength of evidence in observational epidemiological studies.
Collapse
Affiliation(s)
- X Hong
- Department of Epidemiology and Health Statistics, School of Public Health, Southeast University, Nanjing, 210009, China
| | - J C Yin
- Department of Epidemiology and Health Statistics, School of Public Health, Southeast University, Nanjing, 210009, China
| | - B Wang
- Department of Epidemiology and Health Statistics, School of Public Health, Southeast University, Nanjing, 210009, China
| |
Collapse
|
17
|
Xu L, Zhang J, Shen S, Liu Z, Zeng X, Yang Y, Hong X, Chen X. Clinical Frailty Scale and Biomarkers for Assessing Frailty in Elder Inpatients in China. J Nutr Health Aging 2021; 25:77-83. [PMID: 33367466 DOI: 10.1007/s12603-020-1455-8] [Citation(s) in RCA: 7] [Impact Index Per Article: 2.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/13/2022]
Abstract
OBJECTIVE This study aimed to assess the feasibility of the Clinical Frailty Scale (CFS) and clinical biomarkers in assessing the frailty in elder inpatients in China. DESIGN The study was a cross-sectional study. SETTING AND PARTICIPANTS The study included 642 elder inpatients (295 females and 347 males) aged ≥65 years, from the Department of Geriatrics of Zhejiang Hospital between January 2018 and December 2019. MEASUREMENTS All participants underwent a comprehensive geriatric assessment and blood tests. Univariate and multivariate logistic regression was used to analyze the association between risk factors and frailty. RESULTS The average age of the participants was 82.72±8.06 years (range: 65-95 years) and the prevalence of frailty was 39.1% according to the CFS. Frail participants showed significantly lower short physical performance battery (SPPB), basic activities of daily living (ADL) and instrumental activities of daily living (IADL) scores (all p<0.001), and lower hemoglobin, total protein and albumin levels (all P<0.05) than nonfrail participants. Frail participants had higher CRP, D-dimer and fibrinogen levels than nonfrail participants (all p<0.05). Univariate logistic regression analysis showed a significant association between frailty and age, comorbidity, polypharmacy, fall history, SPPB, ADL, and IADL scores, D-dimer, fibrinogen, hemoglobin, total protein and albumin levels (all P<0.05). Multivariate logistic regression analysis indicated that age (odds ratio (OR), 95% confidence interval (CI)= 1.151(1.042-1.272), P=0.006), SPPB scores (OR, 95% CI=0.901(0.601-1.350), P<0.001), and D-dimer (OR, 95% CI=4.857(2.182-6.983), P<0.001), fibrinogen (OR, 95% CI=2.665(0.977-4.254), P<0.001), hemoglobin (OR, 95% CI=0.837(0.725-0.963), P= 0.044), and albumin (OR, 95% CI=0.860 (0.776-1.188), P<0.001) levels were independently associated with frailty in all participants. CONCLUSION Frailty in elder inpatients in China is characterized by older age, a lower SPPB scores, higher D-dimer and fibrinogen levels and lower hemoglobin and albumin levels. Functional decline and malnutrition may be the targets of frailty interventions.
Collapse
Affiliation(s)
- L Xu
- Xujiao Chen. Department of Geriatrics, Zhejiang Hospital, Lingyin Road #12, Hangzhou 310013, People's Republic of China, Tel +86 18069897567, Fax +86 0571 87985100, Email
| | | | | | | | | | | | | | | |
Collapse
|
18
|
You R, Chen J, Hong M, Li J, Hong X. Facile Synthesis of g-C 3N 4/TiO 2/Hectorite Z-Scheme Composite and Its Visible Photocatalytic Degradation of Rhodamine B. Materials (Basel) 2020; 13:E5304. [PMID: 33238637 PMCID: PMC7700213 DOI: 10.3390/ma13225304] [Citation(s) in RCA: 6] [Impact Index Per Article: 1.5] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Subscribe] [Scholar Register] [Received: 10/26/2020] [Revised: 11/15/2020] [Accepted: 11/20/2020] [Indexed: 11/16/2022]
Abstract
A novel g-C3N4/TiO2/hectorite Z-scheme composites with oxygen vacancy (Vo) defects and Ti3+ were synthesized by so-gel method and high temperature solid phase reaction. This composite exhibited high visible photo-catalytic degradation of rhodamine B (RhB). The apparent rate constant of g-C3N4/TiO2/hectorite was 0.01705 min-1, which is approximately 5.38 and 4.88 times that of P25 and g-C3N4, respectively. The enhancement of photo-catalytic efficiency of the composites can be attributed to the great light harvesting ability, high specific surface area and effective separation of electrons(e-) and holes(h+). The F element from Hectorite causes the formation of Vo and Ti3+ in TiO2, making it responsive to visible light. The effective separation of e- and h+ mainly results from Z-scheme transfer of photo-produced electrons in g-C3N4/TiO2 interface. The composites can be easily recycled and the degradation rate of the RhB still reached 84% after five cycles, indicating its good reusability.
Collapse
Affiliation(s)
- Rong You
- School of Environmental and Chemical Engineering, Shanghai University, Shanghai 201900, China; (M.H.); (J.L.); (X.H.)
| | - Jinyang Chen
- School of Environmental and Chemical Engineering, Shanghai University, Shanghai 201900, China; (M.H.); (J.L.); (X.H.)
| | | | | | | |
Collapse
|
19
|
Hong X, Yan M. Response of cardiac autonomic nerve function to different exhaustion exercises. Sci Sports 2020. [DOI: 10.1016/j.scispo.2019.11.005] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/28/2022]
|
20
|
Hong X, Liu SN, Xu FF, Han LL, Jiang P, Wang ZQ, Cui J, Zhang X. Global genetic diversity of Spirometra tapeworms. Trop Biomed 2020; 37:237-250. [PMID: 33612735] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 06/12/2023]
Abstract
Spirometra larvae are etiological agents of human sparganosis. However, the systematics of spirometrid cestodes has long been controversial. In order to determine the current knowledge on the evolution and genetic structure of Spirometra, an exhaustive population diversity analysis of spirometrid cestodes using the mitochondrial gene: cytochrome c oxidase subunit 1 (cox1) was performed. All publicly available cox1 sequences available in the GenBank and 127 new sequencing genes from China were used as the dataset. The haplotype identify, network, genetic differentiation and phylogenetic analysis were conducted successively. A total of 488 sequences from 20 host species, representing four spirometrid tapeworms (S. decipiens, S. ranarum, S. erinaceieuropaei and Sparganum proliferum) and several unclassified American and African isolates from 113 geographical locations in 17 countries, identified 45 haplotypes. The genetic analysis revealed that there are four clades of spirometrid cestodes: Clade 1 (Brazil + USA) and Clade 2 (Argentina + Venezuela) included isolates from America, Clade 3 contained African isolates and one Korean sample, and the remainders from Asia and Australia belonged to Clade 4; unclassified Spirometra from America and Africa should be considered the separate species within the genus; and the taxonomy of two Korea isolates (S. erinaceieuropaei KJ599680 and S. decipiens KJ599679) was still ambiguous and needs to be further identified. In addition, the demographical analyses supported population expansion for the total spirometrid population. In summary, four lineages were found in the spirometrid tapeworm, and further investigation with deeper sampling is needed to elucidate the population structure.
Collapse
Affiliation(s)
- X Hong
- Department of Parasitology, School of Basic Medical Sciences, Zhengzhou University, 40 Daxue Road, Zhengzhou 450052, People's Republic of China
| | - S N Liu
- Department of Parasitology, School of Basic Medical Sciences, Zhengzhou University, 40 Daxue Road, Zhengzhou 450052, People's Republic of China
| | - F F Xu
- Department of Parasitology, School of Basic Medical Sciences, Zhengzhou University, 40 Daxue Road, Zhengzhou 450052, People's Republic of China
| | - L L Han
- Department of Parasitology, School of Basic Medical Sciences, Zhengzhou University, 40 Daxue Road, Zhengzhou 450052, People's Republic of China
| | - P Jiang
- Department of Parasitology, School of Basic Medical Sciences, Zhengzhou University, 40 Daxue Road, Zhengzhou 450052, People's Republic of China
| | - Z Q Wang
- Department of Parasitology, School of Basic Medical Sciences, Zhengzhou University, 40 Daxue Road, Zhengzhou 450052, People's Republic of China
| | - J Cui
- Department of Parasitology, School of Basic Medical Sciences, Zhengzhou University, 40 Daxue Road, Zhengzhou 450052, People's Republic of China
| | - X Zhang
- Department of Parasitology, School of Basic Medical Sciences, Zhengzhou University, 40 Daxue Road, Zhengzhou 450052, People's Republic of China
| |
Collapse
|
21
|
Zhu Z, Huang Q, Hong X, Chen X, Lu Y, Chen Z, Wang C, Meng X, Xu Q, Li S. Isolation and characterization of Salmonella in pork samples collected from retail and wholesale markets in each season from 2016 to 2018 in Wuhan, China. J Appl Microbiol 2019; 128:875-883. [PMID: 31710755 DOI: 10.1111/jam.14515] [Citation(s) in RCA: 8] [Impact Index Per Article: 1.6] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 09/30/2019] [Revised: 10/27/2019] [Accepted: 11/03/2019] [Indexed: 01/08/2023]
Abstract
AIMS To investigate the prevalence and characteristics of Salmonella in pork on sale in Wuhan, Central China. METHODS AND RESULTS A total of 4744 pork samples were collected from retail or wholesale markets in each season from 2016 to 2018. The samples showed an overall Salmonella prevalence of 19·54% (927/4744), among which the samples collected in 2017 (21·67%, 428/1975) possessed a significantly higher prevalence than those collected in 2016 (18·61%, 209/1123) (P = 0·047) or 2018 (17·51%, 290/1656) (P = 0·002), and the samples collected in winter showed the lowest prevalence (15·86%, 177/1116). The Salmonella prevalence was significantly higher among samples from retail markets (25·68%, 283/1102) than wholesale markets (17·68%, 644/3642) (P = 0·000). Antimicrobial resistance of 922 Salmonella strains was tested by determining the minimal inhibitory concentrations using a broth microdilution method. The strains revealed that 98·92% (912/922) were resistant to at least one of the antimicrobial agents, and 80·04% (738/922) were resistant to three or more antimicrobials (MDR). Resistance to sulfamethoxazole/trimethoprim (89·91%), tetracycline (87·20%) and ampicillin (71·69%) was predominant. The proportion of MDR strains in 2017 (93·62%, 396/423) was significantly higher than that in 2016 (63·16%, 132/209) (P = 0·000) or 2018 (69·66%, 202/290) (P = 0·000). No significant difference was observed in the proportions of MDR strains between wholesale markets (76·07%, 213/280) and retail markets (80·53%, 517/642) (P = 0·075). Multi-locus sequence typing for 554 of the isolates revealed 20 different sequence types (STs), among which ST40 (38·27%, 212/554), ST34 (18·41%, 102/554) and ST469 (14·46%, 79/554) were dominant. CONCLUSIONS A high risk of Salmonella prevalence and antimicrobial resistance was observed in pork in Wuhan. The risk varies between different sampling years, seasons and market types. SIGNIFICANCE AND IMPACT OF THE STUDY Providing baseline data on Salmonella contamination in pork on sale in Central China.
Collapse
Affiliation(s)
- Z Zhu
- Key Laboratory of Preventive Veterinary Medicine in Hubei Province, College of Veterinary Medicine, Huazhong Agricultural University, Wuhan, P.R. China
| | - Q Huang
- Key Laboratory of Preventive Veterinary Medicine in Hubei Province, College of Veterinary Medicine, Huazhong Agricultural University, Wuhan, P.R. China
| | - X Hong
- Key Laboratory of Preventive Veterinary Medicine in Hubei Province, College of Veterinary Medicine, Huazhong Agricultural University, Wuhan, P.R. China
| | - X Chen
- Key Laboratory of Preventive Veterinary Medicine in Hubei Province, College of Veterinary Medicine, Huazhong Agricultural University, Wuhan, P.R. China
| | - Y Lu
- Key Laboratory of Preventive Veterinary Medicine in Hubei Province, College of Veterinary Medicine, Huazhong Agricultural University, Wuhan, P.R. China
| | - Z Chen
- Wuhan Agricultural Comprehensive Law Enforcement Inspector Corps, Wuhan, P.R. China
| | - C Wang
- Wuhan Agricultural Comprehensive Law Enforcement Inspector Corps, Wuhan, P.R. China
| | - X Meng
- Key Laboratory of Preventive Veterinary Medicine in Hubei Province, College of Veterinary Medicine, Huazhong Agricultural University, Wuhan, P.R. China
| | - Q Xu
- Key Laboratory of Preventive Veterinary Medicine in Hubei Province, College of Veterinary Medicine, Huazhong Agricultural University, Wuhan, P.R. China
| | - S Li
- Key Laboratory of Preventive Veterinary Medicine in Hubei Province, College of Veterinary Medicine, Huazhong Agricultural University, Wuhan, P.R. China
| |
Collapse
|
22
|
Gao QQ, Wang HQ, Lv XP, Wei L, Song HY, Wang X, Liu J, Chen YW, Zhang HQ, Hong X, Han L. [Analysis of outpatient utilization of pneumoconiosis patients in Jiangsu province]. Zhonghua Lao Dong Wei Sheng Zhi Ye Bing Za Zhi 2019; 37:670-673. [PMID: 31594123 DOI: 10.3760/cma.j.issn.1001-9391.2019.09.008] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Subscribe] [Scholar Register] [Indexed: 11/05/2022]
Abstract
Objective: To understand the situation and characteristics of out-patient utilization of urban and rural pneumoconiosis patients in Jiangsu province, and to provide a reference for the formulation of relevant policies. Methods: Using a questionnaire on patients with pneumoconiosis and their influencing factors, 120 patients with pneumoconiosis were randomly selected in Nanjing, Wuxi, Suzhou, Yancheng Vocational Defense Institute or CDC. The rate of outpatients with pneumoconiosis in urban and rural areas and the choice of out-patient hospitals were analyzed. Results: Of the 75 patients with severe pneumoconi-related symptoms such as chest tightness and dyspnea in the first two weeks of the survey, 36 (48.0%) lived in cities and 39 (52.0%) lived in rural areas. Patients with pneumoconiosis who live in urban and rural areas have different aggravating conditions within two weeks. Two weeks of aggravated symptoms in outpatient consultations accounted for36 (48.0%) . Of the 36 patients who used outpatient treatment, rural residents mainly chose 8 people from a hospital and a township health hospital, accounting for 34.8%, while 10 people from urban residents chose a nursing home or nursing home, accounting for 40.0%. The main reason why urban and rural pneumoconiosis patients did not go to the doctor is "conscious symptoms are lighter" and "feel that the doctor is useless." Conclusion: The rate of outpatients with pneumoconiosis in Jiangsu province within two weeks is lower than that of ordinary elderly residents. There may be differences in treatment behavior patterns of urban and rural pneumoconiosis patients.Economic factors have a certain influence on the outpatient treatment behavior of pneumoconiosis patients. The recognition of outpatient service is the main factor affecting the outpatient treatment of pneumoconiosis patients. It is very important to popularize the knowledge of pneumoconiosis and do a good job in propaganda of occupational diseases and health education for pneumoconiosis patients. Focusing on the outpatient treatment of pneumoconiosis patients and making targeted medical policies is very important to standardize and improve the rehabilitation of pneumoconiosis patients.
Collapse
Affiliation(s)
- Q Q Gao
- Jiangsu Provincial Center for Disease Control and Prevention. Nanjing 210028, China
| | - H Q Wang
- Institute of Occupational Health and Poisoning Control, China Center for Disease Control and Prevention Beijing 100500, China
| | - X P Lv
- Institute of Occupational Health and Poisoning Control, China Center for Disease Control and Prevention Beijing 100500, China
| | - L Wei
- Nantong University、Nantong 262019, China
| | - H Y Song
- Nanjing Occupational Disease Prevention and Control Hospital. Nanjing 210042, China
| | - X Wang
- Nanjing Occupational Disease Prevention and Control Hospital. Nanjing 210042, China
| | - J Liu
- Suzhou Fifth People's Hospital. Suzhou 215007, China
| | - Y W Chen
- Suzhou Fifth People's Hospital. Suzhou 215007, China
| | - H Q Zhang
- Yancheng Center for Disease Control and Prevention. Yancheng 224000, China
| | - X Hong
- Wuxi Center for Disease Control and Prevention. Wuxi 214023, China
| | - L Han
- Jiangsu Provincial Center for Disease Control and Prevention. Nanjing 210028, China
| |
Collapse
|
23
|
Wei L, Wang HQ, Lv XP, Gao QQ, Song HY, Wang X, Liu J, Chen YW, Zhang HQ, Hong X, Han L. [Analysis of annual hospitalization rate of pneumoconiosis patients and related influencing factors of social security]. Zhonghua Lao Dong Wei Sheng Zhi Ye Bing Za Zhi 2019; 37:656-659. [PMID: 31594119 DOI: 10.3760/cma.j.issn.1001-9391.2019.09.004] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Subscribe] [Scholar Register] [Indexed: 11/05/2022]
Abstract
Objective: To study the main factors that influencing Pneumoconiosis patients' healthcare seeking behaviors. Methods: Conducting a descriptive analysis to analyze the relationship between the annual hospitalization rate and social security status (medical insurance, location of medical insurance, proportion of insurance used for reimbursement of pneumoconiosis, whether there is employment injury insurance at work, whether to apply for compensation after diagnosing pneumoconiosis, whether they receive social assistance and a minimum allowance) , social relationship status of patients (whether there is pneumoconiosis in the family or relatives, whether there is a pneumoconiosis in a friend or a colleague, and whether or not he/she has received financial assistance) , life quality of patients (subjective feelings) and living standard of patients (dietary level) based on data acquired from 120 pneumoconiosis patients. Results: The results of single factor analysis reveal that the location of medical insurance, the proportion of insurance for reimbursement of pneumoconiosis, whether there is employment injury insurance at work, whether to apply for compensation after diagnosing pneumoconiosis are statistically significant in pneumoconiosis patients' hospital utilization ratio (P<0.05) . The place where medical insurance is located is the current place of residence, the reimbursement ratio of medical insurance for pneumoconiosis is listed as 50%-70%, the work unit has medical insurance, those who have not applied for compensation for pneumoconiosis have a higher utilization rate of hospitalization services. The annual hospitalization rate was 73.3%, 80.0%, 60.6%, 63.0%, respectively. Conclusion: The location of patient medical insurance, the proportion of insurance used for reimbursement of pneumoconiosis, whether there is employment injury insurance at work, and whether to apply for compensation after pneumoconiosis are the influencing factors of the patients' annual hospitalization rate.
Collapse
Affiliation(s)
- L Wei
- School of Public Health, Nanjing Medical University, Nanjing 211100, China
| | - H Q Wang
- Institute of Occupational Health and Poisoning Control, China Center for Disease Control and Prevention, Beijing 100050, China
| | - X P Lv
- Institute of Occupational Health and Poisoning Control, China Center for Disease Control and Prevention, Beijing 100050, China
| | - Q Q Gao
- Jiangsu Provincial Center for Disease Control and Prevention, Nanjing 210028, China
| | - H Y Song
- Nanjing Occupational Disease Prevention and Control Hospital, Nanjing 210042, China
| | - X Wang
- Nanjing Occupational Disease Prevention and Control Hospital, Nanjing 210042, China
| | - J Liu
- Suzhou Fifth People's Hospital, Suzhou 215007, China
| | - Y W Chen
- Suzhou Fifth People's Hospital, Suzhou 215007, China
| | - H Q Zhang
- Yancheng Center for Disease Control and Prevention, Yancheng 224000, China
| | - X Hong
- Wuxi Center for Disease Control and Prevention, Wuxi 214023, China
| | - L Han
- Jiangsu Provincial Center for Disease Control and Prevention, Nanjing 210028, China
| |
Collapse
|
24
|
Ji G, Hong X, Chen Z, Tan J, Jiang Q, Peng J, Xu Y, Ma W. [Prevalence of malnutrition status in children and adolescents in Guangdong Province, 2002-2012]. Wei Sheng Yan Jiu 2019; 48:907-912. [PMID: 31875814] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Subscribe] [Scholar Register] [Indexed: 06/10/2023]
Abstract
OBJECTIVE To investigate the prevalence and change of growth retardation, weight loss and malnutrition among children and adolescents aged 6-17 years in Guangdong Province in 2002-2012. METHODS A total of 7264 children and adolescents(3804 boys and 3460 girls) aged 6-17 years were selected in thirteen monitoring points of Guangdong for nutritional survey in 2002, and a total of 2319 children and adolescents(1158 boys and 1161 girls) aged 6-17 years were selected in nine counties/districts of Guangdong for nutritional survey during 2009-2012 through multistage random cluster sampling. The body height and weight of all the children and adolescents were measured. RESULTS The prevalence of growth retardation, weight loss and malnutrition decreased from 10. 0% to 1. 6%, 18. 1% to 8. 0%, and 24. 7% to 9. 3%among children and adolescents in Guangdong from 2002 to 2009-2012. The result of2009-2012 survey indicated the average prevalence of growth retardation were higher in boys(1. 9%) than in girls(1. 1%), and the average prevalence of weight loss and malnutrition was higher in girls(10. 4% and 11. 3%) than in boys(6. 0% and 7. 7%). And the average prevalence of growth retardation, weight loss and malnutrition were all higher in those living in rural area(2. 5%, 12. 4% and 14. 5%) than in city area(0. 8%, 4. 4% and 5. 1%). CONCLUSION Compared with 2002, the prevalence of growth retardation, weight loss and malnutrition in children and adolescents aged 6-17 in Guangdong Province all decreased significantly. The prevalence was still high in girls and those living in rural, and children aged 6-17, thus more attention should be paid to them.
Collapse
Affiliation(s)
- Guiyuan Ji
- Guangdong Provincial Center for Disease Control and Prevention, Guangdong Provincial Institute of Public Health, Guangzhou 511430, China
| | - Xiaomin Hong
- Guangdong Provincial Center for Disease Control and Prevention, Guangdong Provincial Institute of Public Health, Guangzhou 511430, China
| | - Zihui Chen
- Guangdong Provincial Center for Disease Control and Prevention, Guangdong Provincial Institute of Public Health, Guangzhou 511430, China
| | - Jianbin Tan
- Guangdong Provincial Center for Disease Control and Prevention, Guangzhou 511430, China
| | - Qi Jiang
- Guangdong Provincial Center for Disease Control and Prevention, Guangdong Provincial Institute of Public Health, Guangzhou 511430, China
| | - Jiewen Peng
- Guangdong Provincial Center for Disease Control and Prevention, Guangdong Provincial Institute of Public Health, Guangzhou 511430, China
| | - Yanjun Xu
- Guangdong Provincial Center for Disease Control and Prevention, Guangzhou 511430, China
| | - Wenjun Ma
- Guangdong Provincial Center for Disease Control and Prevention, Guangdong Provincial Institute of Public Health, Guangzhou 511430, China
| |
Collapse
|
25
|
Wu D, Hong X, Liu Y, Zhang K, Hu Y, Gu F, Liu Y, Zhao Z, Liu J, Liu L. EP1.01-55 Neoantigen Deletion Leads to Hyperprogressive Disease (HPD) in Non-Small Cell Lung Cancer (NSCLC) Treated with PD-1/PD-L1 Inhibitors. J Thorac Oncol 2019. [DOI: 10.1016/j.jtho.2019.08.2030] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/25/2022]
|
26
|
Hong X, Min SN, Zhang YY, Lin YT, Wang F, Huang Y, Yu GY, Wu LL, Yang HY. TNF-α Suppresses Autophagic Flux in Acinar Cells in IgG4-Related Sialadenitis. J Dent Res 2019; 98:1386-1396. [PMID: 31461632 DOI: 10.1177/0022034519871890] [Citation(s) in RCA: 11] [Impact Index Per Article: 2.2] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/18/2022] Open
Abstract
IgG4-related sialadenitis (IgG4-RS) is a newly recognized immune-mediated systemic fibroinflammatory disease that affects salivary glands and leads to hyposalivation. Tumor necrosis factor-α (TNF-α) is a critical proinflammatory cytokine involved in several salivary gland disorders, but its role and mechanism regarding acinar cell injury in IgG4-RS are unknown. Here, we found that TNF-α level was significantly increased in serum and submandibular gland (SMG) of patients and that serum TNF-α level was negatively correlated with saliva flow rate. Ultrastructural observations of IgG4-RS SMGs revealed accumulation of large autophagic vacuoles, as well as dense fibrous bundles, decreased secretory granules, widened intercellular spaces, swollen mitochondria, and expanded endoplasmic reticulum. Expression levels of LC3 and p62 were both increased in patients' SMGs. TNF-α treatment led to elevated levels of LC3II and p62 in both SMG-C6 cells and cultured human SMG tissues but did not further increase their levels when combined with bafilomycin A1 treatment. Moreover, transfection of Ad-mCherry-GFP-LC3B in SMG-C6 cells confirmed the suppression of autophagic flux after TNF-α treatment. Immunofluorescence imaging revealed that costaining of LC3 and the lysosomal marker LAMP2 was significantly decreased in patients, TNF-α-treated SMG-C6 cells, and cultured human SMGs, indicating a reduction in autophagosome-lysosome fusion. Furthermore, the ratio of pro/mature cathepsin D was elevated in vivo, ex vivo, and in vitro. TNF-α also appeared to induce abnormal acidification of lysosomes in acinar cells, as assessed by lysosomal pH and LysoTracker DND-26 fluorescence intensity. In addition, TNF-α treatment induced transcription factor EB (TFEB) redistribution in SMG-C6 cells, which was consistent with the changes observed in IgG4-RS patients. TNF-α increased the phosphorylation of extracellular signal-regulated kinase (ERK) 1/2, and inhibition of ERK1/2 by U0126 reversed TNF-α-induced TFEB redistribution, lysosomal dysfunction, and autophagic flux suppression. These findings suggest that TNF-α is a key cytokine related to acinar cell injury in IgG4-RS through ERK1/2-mediated autophagic flux suppression.
Collapse
Affiliation(s)
- X Hong
- Department of Oral and Maxillofacial Surgery, Peking University Shenzhen Hospital, Shenzhen Peking University, the Hong Kong University of Science and Technology Medical Center, Shenzhen, P.R. China
| | - S N Min
- Department of Oral and Maxillofacial Surgery, Peking University School and Hospital of Stomatology, Beijing, P.R. China
| | - Y Y Zhang
- Department of Oral and Maxillofacial Surgery, Peking University School and Hospital of Stomatology, Beijing, P.R. China
| | - Y T Lin
- Department of Oral and Maxillofacial Surgery, Peking University Shenzhen Hospital, Shenzhen Peking University, the Hong Kong University of Science and Technology Medical Center, Shenzhen, P.R. China
| | - F Wang
- Department of Oral and Maxillofacial Surgery, Peking University Shenzhen Hospital, Shenzhen Peking University, the Hong Kong University of Science and Technology Medical Center, Shenzhen, P.R. China
| | - Y Huang
- Department of Oral and Maxillofacial Surgery, Peking University School and Hospital of Stomatology, Beijing, P.R. China
| | - G Y Yu
- Department of Oral and Maxillofacial Surgery, Peking University Shenzhen Hospital, Shenzhen Peking University, the Hong Kong University of Science and Technology Medical Center, Shenzhen, P.R. China.,Department of Oral and Maxillofacial Surgery, Peking University School and Hospital of Stomatology, Beijing, P.R. China
| | - L L Wu
- Department of Physiology and Pathophysiology, Peking University School of Basic Medical Sciences, Beijing, P.R. China
| | - H Y Yang
- Department of Oral and Maxillofacial Surgery, Peking University Shenzhen Hospital, Shenzhen Peking University, the Hong Kong University of Science and Technology Medical Center, Shenzhen, P.R. China
| |
Collapse
|
27
|
Vitolo U, Witzig T, Gascoyne R, Scott D, Zhang Q, Jurczak W, Özcan M, Hong X, Zhu J, Jin J, Belada D, Bergua J, Piazza F, Mócikova H, Molinari A, Yoon D, Cavallo F, Tani M, Izutsu K, Kato K, Czuczman M, Hersey S, Kilcoyne A, Russo J, Hudak K, Zhang J, Chiappella A, Nowakowski G. ROBUST: First report of phase III randomized study of lenalidomide/R-CHOP (R2
-CHOP) vs placebo/R-CHOP in previously untreated ABC-type diffuse large B-cell lymphoma. Hematol Oncol 2019. [DOI: 10.1002/hon.5_2629] [Citation(s) in RCA: 71] [Impact Index Per Article: 14.2] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/07/2022]
Affiliation(s)
- U. Vitolo
- Division of Hematology; A.O.U. Città della Salute e della Scienza Hospital and University; Torino Italy
| | - T.E. Witzig
- Division of Hematology; Mayo Clinic; Rochester MN United States
| | - R.D. Gascoyne
- Centre for Lymphoid Cancer; British Columbia Cancer; Vancouver BC Canada
| | - D.W. Scott
- Centre for Lymphoid Cancer; British Columbia Cancer; Vancouver BC Canada
| | - Q. Zhang
- Harbin Medical University Cancer Hospital; Harbin Heilongjiang China
| | - W. Jurczak
- Department of Hematology; Jagiellonian University; Krakow Poland
| | - M. Özcan
- Department of Hematology; Ankara University; Ankara Turkey
| | - X. Hong
- Cancer Hospital; Fudan University; Shanghai China
| | - J. Zhu
- Beijing Cancer Hospital; Beijing China
| | - J. Jin
- The First Affiliated Hospital of Medical School of Zhejiang University; First Hospital of Zhejiang Province; Zhejiang Hangzhou China
| | - D. Belada
- Fourth Department of Internal Medicine-Hematology; Charles University Hospital and Faculty of Medicine; Hradec Králové Czech Republic
| | - J.M. Bergua
- Servicio de Hematologia; Hospital Universitario San Pedro de Alcántara; Cáceres Spain
| | - F. Piazza
- Division of Hematology, Department of Medicine; University of Padova and Azienda Ospedaliera di Padova; Padova Italy
| | - H. Mócikova
- Department of Internal Medicine and Haematology; Faculty Hospital Kralovske Vinohrady; Prague Czech Republic
| | | | - D.H. Yoon
- Department of Oncology, Asan Medical Center; University of Ulsan College of Medicine; Seoul South Korea Republic of Korea
| | - F. Cavallo
- AOU Città della Salute e della Scienza di Torino; Turin Italy
| | - M. Tani
- U.O. Ematologia, Dipartimento Oncologia e Ematologia; Ospedale Santa Maria delle Croci; Ravenna Italy
| | - K. Izutsu
- National Cancer Center Hospital; Tokyo Japan
| | - K. Kato
- Department of Medicine and Biosystemic Science; Kyushu University Faculty of Medicine; Fukuoka City Japan
| | - M. Czuczman
- Clinical Research & Development; Celgene Corporation; Summit NJ USA
| | - S. Hersey
- Clinical Research & Development; Celgene Corporation; Summit NJ USA
| | - A. Kilcoyne
- Clinical Research & Development; Celgene Corporation; Summit NJ USA
| | - J. Russo
- Clinical Research & Development; Celgene Corporation; Summit NJ USA
| | - K. Hudak
- Clinical Research & Development; Celgene Corporation; Summit NJ USA
| | - J. Zhang
- Clinical Research & Development; Celgene Corporation; Summit NJ USA
| | - A. Chiappella
- Division of Hematology; A.O.U. Città della Salute e della Scienza Hospital and University; Torino Italy
| | - G.S. Nowakowski
- Division of Hematology; Mayo Clinic; Rochester MN United States
| | | |
Collapse
|
28
|
Leonard J, Trneny M, Izutsu K, Fowler N, Hong X, Zhang H, Offner F, Scheliga A, Nowakowski G, Pinto A, Re F, Fogliatto L, Scheinberg P, Flinn I, Moreira C, Czuczman M, Kalambakas S, Fustier P, Wu C, Gribben J. AUGMENT PHASE III STUDY: LENALIDOMIDE/RITUXIMAB (R2
) IMPROVED EFFICACY OVER RITUXIMAB/PLACEBO IN RELAPSED/REFRACTORY FOLLICULAR PATIENTS IRRESPECTIVE OF POD24 STATUS. Hematol Oncol 2019. [DOI: 10.1002/hon.75_2629] [Citation(s) in RCA: 6] [Impact Index Per Article: 1.2] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/06/2022]
Affiliation(s)
- J. Leonard
- Meyer Cancer Center; Weill Cornell Medicine and New York Presbyterian Hospital; New York United States
| | - M. Trneny
- General Hospital; Charles University; Prague Czech Republic
| | - K. Izutsu
- Hematology; National Cancer Center Hospital; Tokyo Japan
| | - N. Fowler
- Department of Lymphoma and Myeloma; The University of Texas MD Anderson Cancer Center; Houston United States
| | - X. Hong
- Hematology; Fudan University Shanghai Cancer Center; Shanghai China
| | - H. Zhang
- Hematology; Tianjin Medical University Cancer Institute and Hospital; Tianjin China
| | | | - A. Scheliga
- Hematology; INCA Instituto Nacional De Câncer; Rio de Janeiro Brazil
| | - G. Nowakowski
- Division of Hematology; Department of Internal Medicine, Mayo Clinic; Rochester United States
| | - A. Pinto
- Hematology; Istituto Nazionale Tumori, Fondazione ‘G. Pascale’, IRCCS; Naples Italy
| | - F. Re
- Hematology; Azienda Ospedaliero-Universitaria di Parma; Parma Italy
| | - L. Fogliatto
- Hematology; Hospital de Clinicas de Porto Alegre; Porto Alegre Brazil
| | - P. Scheinberg
- Hematology; Hospital A Beneficência Portuguesa de São Paulo; São Paulo Brazil
| | - I. Flinn
- Hematology; Sarah Cannon Research Institute/Tennessee Oncology; Nashville United States
| | - C. Moreira
- Hematology; Instituto Português de Oncologia Do Porto Francisco Gentil Epe; Porto Portugal
| | - M. Czuczman
- Global Clinical R&D Hematology/Oncology; Celgene Corporation; Summit United States
| | - S. Kalambakas
- Global Medical Affairs; Celgene Corporation; Summit United States
| | - P. Fustier
- Global Medical Affairs; Celgene International Sarl; Boudry Switzerland
| | - C. Wu
- BioStatistics; Celgene Corporation; Summit United States
| | - J. Gribben
- Centre for Haemato-Oncology; Barts Cancer Institute; London United Kingdom
| |
Collapse
|
29
|
Thieblemont C, Leonard J, Trneny M, Izutsu K, Fowler N, Hong X, Zhang H, Offner F, Scheliga A, Nowakowski G, Pinto A, Re F, Fogliatto L, Scheinberg P, Flinn I, Moreira C, Czuczman M, Kalambakas S, Fustier P, Wu C, Gribben J. POST HOC ANALYSES OF PATIENTS WITH RELAPSED/REFRACTORY MARGINAL ZONE LYMPHOMA WHO RECEIVED LENALIDOMIDE PLUS RITUXIMAB (R 2
) VS RITUXIMAB/PLACEBO (AUGMENT). Hematol Oncol 2019. [DOI: 10.1002/hon.41_2630] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.2] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/10/2022]
Affiliation(s)
- C. Thieblemont
- Hemato-Oncology; APHP, Hopital Saint-Louis; Paris France
| | - J. Leonard
- Meyer Cancer Center; Weill Cornell Medicine and New York Presbyterian Hospital; New York United States
| | - M. Trneny
- General Hospital; Charles University; Prague Czech Republic
| | - K. Izutsu
- Hematology; National Cancer Center Hospital; Tokyo Japan
| | - N. Fowler
- Department of Lymphoma and Myeloma; The University of Texas MD Anderson Cancer Center; Houston United States
| | - X. Hong
- Hematology; Fudan University Shanghai Cancer Center; Shanghai China
| | - H. Zhang
- Hematology; Tianjin Medical University Cancer Institute and Hospital; Tianjin China
| | | | - A. Scheliga
- Hematology; INCA Instituto Nacional De Câncer; Rio de Janeiro Brazil
| | - G. Nowakowski
- Division of Hematology; Department of Internal Medicine, Mayo Clinic; Rochester United States
| | - A. Pinto
- Hematology; Istituto Nazionale Tumori, Fondazione ‘G. Pascale’, IRCCS; Naples Italy
| | - F. Re
- Hematology; Azienda Ospedaliero-Universitaria di Parma; Parma Italy
| | - L. Fogliatto
- Hematology; Hospital de Clinicas de Porto Alegre; Porto Alegre Brazil
| | - P. Scheinberg
- Hematology; Hospital A Beneficência Portuguesa de São Paulo; São Paulo Brazil
| | - I. Flinn
- Hematology; Sarah Cannon Research Institute/Tennessee Oncology; Nashville United States
| | - C. Moreira
- Hematology; Instituto Português de Oncologia Do Porto Francisco Gentil Epe; Porto Portugal
| | - M. Czuczman
- Global Clinical R&D Hematology/Oncology; Celgene Corporation; Summit United States
| | - S. Kalambakas
- Global Medical Affairs; Celgene Corporation; Summit United States
| | - P. Fustier
- Global Medical Affairs; Celgene International Sarl; Boudry Switzerland
| | - C. Wu
- BioStatistics; Celgene Corporation; Summit United States
| | - J. Gribben
- Centre for Haemato-Oncology; Barts Cancer Institute; London United Kingdom
| |
Collapse
|
30
|
Leonard J, Trněny M, Izutsu K, Fowler N, Hong X, Zhang H, Offner F, Scheliga A, Nowakowski G, Pinto A, Re F, Fogliatto L, Scheinberg P, Flinn I, Moreira C, Tabah A, Abouzaid S, Kalambakas S, Fustier P, Wu C, Gribben J. HEALTH-RELATED QUALITY OF LIFE (HRQoL) IN RELAPSED/REFRACTORY (R/R) INDOLENT NHL IN THE PHASE 3 AUGMENT TRIAL OF RITUXIMAB (R) PLUS LENALIDOMIDE (R 2
) VERSUS R PLUS PLACEBO. Hematol Oncol 2019. [DOI: 10.1002/hon.45_2630] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.4] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/06/2022]
Affiliation(s)
- J.P. Leonard
- Meyer Cancer Center; Weill Cornell Medicine and New York Presbyterian Hospital; New York United States
| | - M. Trněny
- First Department of Medicine; Charles University Hospital; Prague Czech Republic
| | - K. Izutsu
- Department of Hematology; National Cancer Center Hospital; Tokyo Japan
| | - N.H. Fowler
- Department of Lymphoma and Myeloma; Division of Cancer Medicine, The University of Texas MD Anderson Cancer Center; Houston United States
| | - X. Hong
- Department of Medical Oncology; Fudan University Shanghai Cancer Center; Shanghai China
| | - H. Zhang
- Department of Lymphoma; Tianjin Medical University Cancer Institute and Hospital; Tianjin China
| | - F. Offner
- Department of Clinical Hematology; Universitair Ziekenhuis (UZ) Gent; Gent Belgium
| | - A. Scheliga
- Oncology Clinic; Instituto Nacional De Câncer (INCA); Rio de Janeiro Brazil
| | - G. Nowakowski
- Center for Individualized Medicine; Mayo Clinic; Rochester United States
| | - A. Pinto
- Istituto Nazionale per lo Studio e la Cura dei Tumori; Fondazione Giovanni Pascale, IRCCS; Naples Italy
| | - F. Re
- Ematologia e Centro Trapianti Midollo Osseo (CTMO); Azienda Ospedaliero-Universitaria di Parma; Parma Italy
| | - L.M. Fogliatto
- Serviço Hematologia e Transplante de Medula Ossea; Hospital de Clinicas de Porto Alegre; Porto Alegre Brazil
| | - P. Scheinberg
- Division of Hematology; Hospital A Beneficência Portuguesa; São Paulo Brazil
| | - I.W. Flinn
- Sarah Cannon Research Institute (SCRI); Tennessee Oncology Nashville; Nashville United States
| | - C. Moreira
- Instituto Português de Oncologia; Porto Francisco Gentil Epe; Porto Portugal
| | - A. Tabah
- US Health Economics and Outcomes Research; Celgene Corporation; Summit United States
| | - S. Abouzaid
- Global Pricing and Market Access; Celgene Corporation; Summit United States
| | - S. Kalambakas
- Clinical Research Science; Celgene Corporation; Summit United States
| | - P. Fustier
- Clinical Research Science; Celgene International; Boudry Switzerland
| | - C. Wu
- Statistics; Celgene International; Boudry Switzerland
| | - J.G. Gribben
- Centre for Haemato-Oncology; Barts Cancer Institute, Queen Mary University of London; London United Kingdom
| |
Collapse
|
31
|
Gribben J, Trneny M, Izutsu K, Fowler N, Hong X, Zhang H, Offner F, Scheliga A, Nowakowski G, Pinto A, Re F, Fogliatto L, Scheinberg P, Flinn I, Moreira C, Czuczman M, Kalambakas S, Fustier P, Wu C, Leonard J. AUGMENT: RELAPSED/REFRACTORY INDOLENT NHL PATIENTS WERE MORE SENSITIVE TO NEXT TREATMENT FOLLOWING LENALIDOMIDE/RITUXIMAB (R 2
) THAN RITUXIMAB/PLACEBO. Hematol Oncol 2019. [DOI: 10.1002/hon.42_2630] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.2] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/12/2022]
Affiliation(s)
- J. Gribben
- Centre for Haemato-Oncology; Barts Cancer Institute; London United Kingdom
| | - M. Trneny
- General Hospital; Charles University; Prague Czech Republic
| | - K. Izutsu
- Hematology; National Cancer Center Hospital; Tokyo Japan
| | - N.H. Fowler
- Department of Lymphoma and Myeloma; The University of Texas MD Anderson Cancer Center; Houston United States
| | - X. Hong
- Department of Medical Oncology; Fudan University Shanghai Cancer Center; Shanghai China
| | - H. Zhang
- Hematology; Tianjin Medical University Cancer Institute and Hospital; Tianjin China
| | | | - A. Scheliga
- Hematology; INCA Instituto Nacional De Câncer; Rio de Janeiro Brazil
| | - G. Nowakowski
- Division of Hematology; Department of Internal Medicine, Mayo Clinic; Rochester United States
| | - A. Pinto
- Hematology; Istituto Nazionale Tumori, Fondazione ‘G. Pascale’, IRCCS; Naples Italy
| | - F. Re
- Hematology; Azienda Ospedaliero-Universitaria di Parma; Parma Italy
| | - L. Fogliatto
- Hematology; Hospital de Clinicas de Porto Alegre; Porto Alegre Brazil
| | - P. Scheinberg
- Hematology; Hospital A Beneficência Portuguesa de São Paulo; São Paulo Brazil
| | - I. Flinn
- Hematology; Sarah Cannon Research Institute/Tennessee Oncology; Nashville United States
| | - C. Moreira
- Hematology; Instituto Português de Oncologia Do Porto Francisco Gentil Epe; Porto Portugal
| | - M. Czuczman
- Global Clinical R&D Hematology/Oncology; Celgene Corporation; Summit United States
| | - S. Kalambakas
- Global Medical Affairs; Celgene Corporation; Summit United States
| | - P. Fustier
- Global Medical Affairs; Celgene International Sarl; Boudry Switzerland
| | - C. Wu
- BioStatistics; Celgene Corporation; Summit United States
| | - J. Leonard
- Meyer Cancer Center; Weill Cornell Medicine and New York Presbyterian Hospital; New York United States
| |
Collapse
|
32
|
Gribben J, Trneny M, Izutsu K, Fowler N, Hong X, Zhang H, Offner F, Scheliga A, Nowakowski G, Pinto A, Re F, Fogliatto L, Scheinberg P, Flinn I, Moreira C, Czuczman M, Kalambakas S, Fustier P, Wu C, Leonard J. PS1252 PATIENTS WITH RELAPSED/REFRACTORY INDOLENT NON-HODGKIN LYMPHOMA WERE MORE SENSITIVE TO NEXT TREATMENT FOLLOWING LENALIDOMIDE/RITUXIMAB (R2) THAN RITUXIMAB/PLACEBO (AUGMENT). Hemasphere 2019. [DOI: 10.1097/01.hs9.0000563288.81673.b1] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/25/2022] Open
|
33
|
Yu GY, Hong X, Li W, Zhang YY, Gao Y, Chen Y, Zhang ZY, Xie XY, Li ZG, Liu YY, Su JZ, Zhu WX, Sun ZP. [Clinicopathological characteristics and diagnosis of IgG4related sialadenitis]. Beijing Da Xue Xue Bao Yi Xue Ban 2019; 51:1-3. [PMID: 30773535 DOI: 10.19723/j.issn.1671-167x.2019.01.001] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.2] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Subscribe] [Scholar Register] [Indexed: 01/13/2023]
Abstract
Immunoglobulin G4-related sialadenitis (IgG4-RS) is a newly recognized immune-mediated disease and one of immunoglobulin G4-related diseases (IgG4-RD). Our multidisciplinary research group investigated the clinicopathological characteristics and diagnosis of IgG4-RS during the past 10 years. Clinically, it showed multiple bilateral enlargement of major salivary glands (including sublingual and accessory parotid glands) and lacrimal glands. The comorbid diseases of head and neck region including rhinosinusitis, allergic rhinitis, and lymphadenopathy were commonly seen, which could occur more early than enlargement of major salivary glands. Internal organ involvements, such as autoimmune pancreatitis, sclerosing cholangitis, and interstitial pneumonia could also be seen. Thirty-five (38.5%) patients had the symptom of xerostomia. Saliva flow at rest was lower than normal. Secretory function was reduced more severely in the submandibular glands than in the parotid glands. Serum levels of IgG4 were elevated in almost all the cases and the majority of the patients had increased IgE levels. CT, ultrasonography, and sialography showed their imaging characteristics. Histologically it showed marked lymphoplasmacytic inflammation, large irregular lymphoid follicles with expanded germinal centers, prominent cellular interlobular fibrosis, eosinophil infiltration, and obliterative phlebitis. Their immunohistological examination showed marked IgG-positive and IgG4-positive plasma cell infiltration and high IgG4/IgG ratio. The disease could be divided into three stages according to severity of glandular fibrosis. The serum IgG4 level was higher and the saliva secretion lower as glandular fibrosis increased. IgG4-RS should be differentiated from other diseases with enlargement of major salivary gland and lacrimal gland, such as primary Sjögren syndrome, chronic obstructive submandibular sialadenitis, and eosinophilic hyperplastic lymphogranuloma.
Collapse
Affiliation(s)
- G Y Yu
- Department of Oral & Maxillofacial Surgery, Peking University School and Hospital of Stomatology & National Engineering Laboratory for Digital and Material Technology of Stomatology & Beijing Key Laboratory of Digital Stomatology, Beijing 100081, China.,Center of Stomatology, Peking University Shenzhen Hospital, Shenzhen 518036, Guangdong, China
| | - X Hong
- Department of Oral & Maxillofacial Surgery, Peking University School and Hospital of Stomatology & National Engineering Laboratory for Digital and Material Technology of Stomatology & Beijing Key Laboratory of Digital Stomatology, Beijing 100081, China.,Center of Stomatology, Peking University Shenzhen Hospital, Shenzhen 518036, Guangdong, China
| | - W Li
- Department of Oral & Maxillofacial Surgery, Peking University School and Hospital of Stomatology & National Engineering Laboratory for Digital and Material Technology of Stomatology & Beijing Key Laboratory of Digital Stomatology, Beijing 100081, China
| | - Y Y Zhang
- Department of Oral & Maxillofacial Surgery, Peking University School and Hospital of Stomatology & National Engineering Laboratory for Digital and Material Technology of Stomatology & Beijing Key Laboratory of Digital Stomatology, Beijing 100081, China
| | - Y Gao
- Department of Oral Pathology, Peking University School and Hospital of Stomatology, Beijing 100081, China
| | - Y Chen
- Department of Oral Pathology, Peking University School and Hospital of Stomatology, Beijing 100081, China
| | - Z Y Zhang
- Department of Oral Radiology, Peking University School and Hospital of Stomatology, Beijing 100081, China
| | - X Y Xie
- Department of Oral Radiology, Peking University School and Hospital of Stomatology, Beijing 100081, China
| | - Z G Li
- Department of Rheumatology and Immunology, Peking University People's Hospital, Beijing, 100044, China
| | - Y Y Liu
- Department of Rheumatology and Immunology, Peking University People's Hospital, Beijing, 100044, China
| | - J Z Su
- Department of Oral & Maxillofacial Surgery, Peking University School and Hospital of Stomatology & National Engineering Laboratory for Digital and Material Technology of Stomatology & Beijing Key Laboratory of Digital Stomatology, Beijing 100081, China
| | - W X Zhu
- Department of Oral & Maxillofacial Surgery, Peking University School and Hospital of Stomatology & National Engineering Laboratory for Digital and Material Technology of Stomatology & Beijing Key Laboratory of Digital Stomatology, Beijing 100081, China
| | - Z P Sun
- Department of Oral Radiology, Peking University School and Hospital of Stomatology, Beijing 100081, China
| |
Collapse
|
34
|
Zheng F, Tang D, Xu H, Xu Y, Dai W, Zhang X, Hong X, Liu D, Dai Y. Genomewide analysis of 6-methyladenine DNA in peripheral blood mononuclear cells of systemic lupus erythematosus. Lupus 2019; 28:359-364. [PMID: 30744524 DOI: 10.1177/0961203319828520] [Citation(s) in RCA: 3] [Impact Index Per Article: 0.6] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/17/2022]
Abstract
Aim The aim of this paper is to explore the expression of 6-methyladenine (6mA) DNA and to elucidate its gene regulation role in systemic lupus erythematosus (SLE). Methods Twenty SLE patients and 20 normal control healthy individuals (HCs) were included in this study. Genomic DNA was isolated from peripheral blood mononuclear cells and subsequently underwent 6mA-immunoprecipitation-sequencing (6mA-IP-Seq) after DNA quality control and 6mA precipitation. Bioinformation analysis was applied to the raw data comparing 6mA levels between SLE patients and HCs. Results We identified 5462 hypermethylation and 431 hypomethylation genes in PBMCs of individuals with SLE, which indicated that a high level of 6mA participates in the pathogenesis of SLE. Gene ontology analysis revealed that hypermethylation genes might regulate the inflammatory process, which has been well documented in the pathogenesis of SLE. Conclusion 6mA may be involved in the initial development of SLE, which may lead to its potential use as an early diagnostic marker and therapeutic target.
Collapse
Affiliation(s)
- F Zheng
- Department of Nephrology, The Second Clinical Medical College, Shenzhen People's Hospital, Jinan University, Shenzhen, Guangdong, China
- Clinical Medical Research Center, The Second Clinical Medical College, Shenzhen People's Hospital, Jinan University, Shenzhen, Guangdong, China
| | - D Tang
- Clinical Medical Research Center, The Second Clinical Medical College, Shenzhen People's Hospital, Jinan University, Shenzhen, Guangdong, China
| | - H Xu
- Department of Nephrology, The Second Clinical Medical College, Shenzhen People's Hospital, Jinan University, Shenzhen, Guangdong, China
| | - Y Xu
- Clinical Medical Research Center, The Second Clinical Medical College, Shenzhen People's Hospital, Jinan University, Shenzhen, Guangdong, China
| | - W Dai
- College of Natural Science, University of Texas at Austin, Austin, Texas, USA
| | - X Zhang
- Department of Nephrology, The Second Clinical Medical College, Shenzhen People's Hospital, Jinan University, Shenzhen, Guangdong, China
| | - X Hong
- Department of Rheumatology and Immunology, The Second Clinical Medical College, Shenzhen People's Hospital, Jinan University, Shenzhen, Guangdong, China
| | - D Liu
- Department of Rheumatology and Immunology, The Second Clinical Medical College, Shenzhen People's Hospital, Jinan University, Shenzhen, Guangdong, China
| | - Y Dai
- Clinical Medical Research Center, The Second Clinical Medical College, Shenzhen People's Hospital, Jinan University, Shenzhen, Guangdong, China
| |
Collapse
|
35
|
Hong X, Bao CS, Zheng WL. Inference on Injury Mechanism of Ankle Fracture by Lauge-Hansen Classification. Fa Yi Xue Za Zhi 2018; 34:512-515. [PMID: 30468054 DOI: 10.12116/j.issn.1004-5619.2018.05.015] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.2] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Subscribe] [Scholar Register] [Received: 07/16/2018] [Indexed: 11/30/2022]
Abstract
OBJECTIVES To explore the injury mechanism of ankle fracture inferred by the Lauge-Hansen classification with the application of medical imageology and its application value in forensic medicine. METHODS A total of 32 ankle fracture cases with known injury mechanism were collected from January 2013 to May 2018, which were identified in Yongkang Public Security Bureau, Zhejiang Province. The Lauge-Hansen classification of ankle fracture was performed by three forensic experts based on the data of X-ray and CT image. Fisher's exact test and Kappa consistency analysis were performed by SPSS 20.0 statistical software to compare the results of the Lauge-Hansen classification with the injury mechanism of ankle fracture obtained through the criminal evidence. RESULTS In 32 cases, 84.4% (27/32) ankle fractures were classified according to the Lauge-Hansen classification based on medical imaging. The mechanism of ankle fracture identified by the Lauge-Hansen classification was consistent with that obtained through the criminal evidence. CONCLUSIONS Based on medical imaging, the Lauge-Hansen classification can be well applied to infer the injury mechanism of ankle fracture in part cases, and provide objective evidence for the crime scene reconstruction of criminal cases.
Collapse
Affiliation(s)
- X Hong
- Department of Technology, People's Procuratorate of Zhejiang Province, Hangzhou 310012, China
| | - C S Bao
- Department of Technology, People's Procuratorate of Zhejiang Province, Hangzhou 310012, China
| | - W L Zheng
- Criminal Police Brigade of Yongkang Public Security Bureau, Yongkang 321300, China
| |
Collapse
|
36
|
Song Y, Hong X, Huang H, Bai B, Zhang H, Ke X, Shi Y, Zhu J, Lu G, Liebscher S, Cai C. Safety and efficacy of pralatrexate in patients with relapsed or refractory peripheral T-cell lymphoma from China. Ann Oncol 2018. [DOI: 10.1093/annonc/mdy437.008] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/13/2022] Open
|
37
|
Shi Y, Zhang Q, Han X, Song Y, Qin Y, Hong X, Ke X, Feng J, Wang D, Li W, Su H, Zhang Y, Zhang H, Yang J, Liu L, Zhang X, Liu E, Jiang W, Liu S, Luk A. First china-manufactured proposed rituximab biosimilar met primary efficacy and safety endpoints in CD20-positive diffuse large B-cell lymphoma (generics). Ann Oncol 2018. [DOI: 10.1093/annonc/mdy437.005] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/12/2022] Open
|
38
|
Toh Z, Gu Q, Seah T, Wong W, McNab J, Chuang K, Hong X, Tang P. Increased white matter connectivity seen in young judo athletes with MRI. Clin Radiol 2018. [DOI: 10.1016/j.crad.2018.06.003] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/28/2022]
|
39
|
Ying Y, Hong X, Xu X, Ma K, He J, Zhu F. A novel mutation +5904 C>T of RUNX1 site in the erythroid cell-specific regulatory element decreases the ABO antigen expression in Chinese population. Vox Sang 2018; 113:594-600. [PMID: 29978484 DOI: 10.1111/vox.12676] [Citation(s) in RCA: 21] [Impact Index Per Article: 3.5] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 01/01/2018] [Revised: 04/16/2018] [Accepted: 06/10/2018] [Indexed: 12/11/2022]
Abstract
BACKGROUND An erythroid cell-specific regulatory element (+5·8-kb) in the first intron of ABO is responsible for the antigen differential expression and the regulatory activity of the element was affected by the nucleotide mutation in the +5·8-kb region. Currently, many individuals with ABO subgroups were found in the Chinese population, but there was little information about the function of +5·8-kb region in these individuals. Here, we studied the mechanism of the mutation in the +5·8-kb region responsible for reducing of antigen expression in 30 ABO subtype Chinese individuals without mutation in the coding region or splicing site. MATERIALS AND METHODS The nucleotide sequence of the partial intron 1 covering the +5·8-kb site was amplified and directly sequenced. The haplotype with the novel mutation was obtained by the TOPO TA cloning. Both of the ABO promoter and the +5·8 kb regulatory element were subcloned into the basic luciferase reporter plasmid using the double endonuclease digestion. The promoter activity was examined by the dual-luciferase report vector with K562 cells. RESULTS A novel nucleotide substitution +5904 C>T located at RUNX1-binding site in the +5·8 kb site was identified from three individuals with B subtypes. +5890 T>G were found in three Bel and one Ael phenotypes. Cotransfection and luciferase assays demonstrated that the +5904 C>T could obviously reduce activity of the +5·8 kb site. CONCLUSION The study suggested that the transcriptional activity of the +5·8 kb site could be downregulated by the single point mutation of RUNX1 motif, leading to reduction in A or B antigen expression.
Collapse
Affiliation(s)
- Y Ying
- Blood Center of Zhejiang Province, Hangzhou, China
- Key Laboratory of Blood Safety Research of Zhejiang Province, Hangzhou, China
| | - X Hong
- Blood Center of Zhejiang Province, Hangzhou, China
- Key Laboratory of Blood Safety Research of Zhejiang Province, Hangzhou, China
| | - X Xu
- Blood Center of Zhejiang Province, Hangzhou, China
- Key Laboratory of Blood Safety Research of Zhejiang Province, Hangzhou, China
| | - K Ma
- Blood Center of Zhejiang Province, Hangzhou, China
- Key Laboratory of Blood Safety Research of Zhejiang Province, Hangzhou, China
| | - J He
- Blood Center of Zhejiang Province, Hangzhou, China
- Key Laboratory of Blood Safety Research of Zhejiang Province, Hangzhou, China
| | - F Zhu
- Blood Center of Zhejiang Province, Hangzhou, China
- Key Laboratory of Blood Safety Research of Zhejiang Province, Hangzhou, China
| |
Collapse
|
40
|
Lloyd CE, Nouwen A, Sartorius N, Ahmed HU, Alvarez A, Bahendeka S, Basangwa D, Bobrov AE, Boden S, Bulgari V, Burti L, Chaturvedi SK, Cimino LC, Gaebel W, de Girolamo G, Gondek TM, de Braude MG, Guntupalli A, Heinze MG, Ji L, Hong X, Khan A, Kiejna A, Kokoszka A, Kamala T, Lalic NM, Lecic Tosevski D, Mankovsky B, Li M, Musau A, Müssig K, Ndetei D, Rabbani G, Srikanta SS, Starostina EG, Shevchuk M, Taj R, Vukovic O, Wölwer W, Xin Y. Prevalence and correlates of depressive disorders in people with Type 2 diabetes: results from the International Prevalence and Treatment of Diabetes and Depression (INTERPRET-DD) study, a collaborative study carried out in 14 countries. Diabet Med 2018; 35:760-769. [PMID: 29478265 DOI: 10.1111/dme.13611] [Citation(s) in RCA: 69] [Impact Index Per Article: 11.5] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Accepted: 02/21/2018] [Indexed: 01/23/2023]
Abstract
AIMS To assess the prevalence and management of depressive disorders in people with Type 2 diabetes in different countries. METHODS People with diabetes aged 18-65 years and treated in outpatient settings were recruited in 14 countries and underwent a psychiatric interview. Participants completed the Patient Health Questionnaire and the Problem Areas in Diabetes scale. Demographic and medical record data were collected. RESULTS A total of 2783 people with Type 2 diabetes (45.3% men, mean duration of diabetes 8.8 years) participated. Overall, 10.6% were diagnosed with current major depressive disorder and 17.0% reported moderate to severe levels of depressive symptomatology (Patient Health Questionnaire scores >9). Multivariable analyses showed that, after controlling for country, current major depressive disorder was significantly associated with gender (women) (P<0.0001), a lower level of education (P<0.05), doing less exercise (P<0.01), higher levels of diabetes distress (P<0.0001) and a previous diagnosis of major depressive disorder (P<0.0001). The proportion of those with either current major depressive disorder or moderate to severe levels of depressive symptomatology who had a diagnosis or any treatment for their depression recorded in their medical records was extremely low and non-existent in many countries (0-29.6%). CONCLUSIONS Our international study, the largest of this type ever undertaken, shows that people with diabetes frequently have depressive disorders and also significant levels of depressive symptoms. Our findings indicate that the identification and appropriate care for psychological and psychiatric problems is not the norm and suggest a lack of the comprehensive approach to diabetes management that is needed to improve clinical outcomes.
Collapse
Affiliation(s)
- C E Lloyd
- The Open University, School of Health, Wellbeing and Social Care, UK
| | - A Nouwen
- Department of Psychology, Middlesex University, UK
| | - N Sartorius
- Association for the Improvement of Mental Health Programmes, Switzerland
| | - H U Ahmed
- Child Adolescent & Family Psychiatry, National Institute of Mental Health (NIMH), Dhaka, Bangladesh
| | - A Alvarez
- Hospital Italiano de Buenos Aires, Argentina
| | - S Bahendeka
- Mother Kevin Post Graduate Medical School, Uganda Martyrs University, Kampala, Uganda
| | - D Basangwa
- Mother Kevin Post Graduate Medical School, Uganda Martyrs University, Kampala, Uganda
| | - A E Bobrov
- Federal Medical Research Centre for Psychiatry and Narcology, Moscow, Russia
| | - S Boden
- The Open University, School of Health, Wellbeing and Social Care, UK
| | - V Bulgari
- Psychiatric Epidemiology and Evaluation Unit, Saint John of God Clinical Research Centre, Brescia, Italy
- PhD School in Psychology, Catholic University of the Sacred Heart, Milan, Italy
| | - L Burti
- Department of Neurosciences, Biomedicine and Movement Sciences, University of Verona, Italy
| | - S K Chaturvedi
- National Institute of Mental Health & Neurosciences, Bangalore, India
| | | | - W Gaebel
- Department of Psychiatry and Psychotherapy, Medical Faculty, Heinrich Heine University, Düsseldorf, Germany
| | - G de Girolamo
- Psychiatric Epidemiology and Evaluation Unit, Saint John of God Clinical Research Centre, Brescia, Italy
| | - T M Gondek
- Department of Psychiatry, Wroclaw Medical University, Wroclaw, Poland
| | | | - A Guntupalli
- School of Health, Wellbeing and Social Care, The Open University, UK
| | - M G Heinze
- Universidad Nacional Autónoma de México, Mexico City, Mexico
| | - L Ji
- People's Hospital, Peking University, Beijing, China
| | - X Hong
- Department of Psychological Medicine, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China
| | - A Khan
- Pakistan Institute of Medical Sciences, Pakistan
| | - A Kiejna
- University of Lower Silesia, Wroclaw, Poland
- Department of Psychiatry, Medical University, Wroclaw, Poland
| | - A Kokoszka
- II Department of Psychiatry, Medical University of Warsaw, Warszawa, Poland
| | - T Kamala
- Diabetes Centre and Jnana Sanjeevini Medical Centre, Bangalore, India
| | - N M Lalic
- Clinic for Endocrinology, Belgrade University School of Medicine, Serbian Academy of Sciences and Arts, Belgrade
| | - D Lecic Tosevski
- Institute of Mental Health, Belgrade University School of Medicine, Serbian Academy of Sciences and Arts, Belgrade, Serbia
| | - B Mankovsky
- Department of Diabetology, National Medical Academy for Postgraduate Education, Ukraine
| | - M Li
- School of Nursing, Peking University, Beijing, China
| | - A Musau
- Africa Mental Health Foundation, Kenya
| | - K Müssig
- Institute for Clinical Diabetology, German Diabetes Centre
- Leibniz Centre for Diabetes Research at Heinrich Heine University Düsseldorf, Düsseldorf, Germany
- Department of Endocrinology and Diabetology, Medical Faculty, Heinrich Heine University, Düsseldorf, Germany
- German Centre for Diabetes Research (DZD), München-Neuherberg, Germany
| | - D Ndetei
- University of Nairobi, Africa Mental Health Foundation, Kenya
| | - G Rabbani
- Popular Medical College, Dhaka, Bangladesh
| | - S S Srikanta
- Samatvam Endocrinology Diabetes Centre and Jnana Sanjeevini Medical Centre, Bangalore, India
| | - E G Starostina
- Department of Endocrinology, Moscow Regional Clinical and Research Institute, Russia
| | - M Shevchuk
- Department of Diabetology, National Medical Academy for Postgraduate Education, Kiev, Ukraine
| | - R Taj
- Pakistan Institute of Medical Sciences, Pakistan
| | - O Vukovic
- Institute of Mental Health, Belgrade University School of Medicine, Serbian Academy of Sciences and Arts, Belgrade, Serbia
| | - W Wölwer
- Department of Psychiatry and Psychotherapy, Medical Faculty, Heinrich Heine University, Düsseldorf, Germany
| | - Y Xin
- Clinical Research Centre, Peking University Sixth Hospital, Clinical Research Centre, Peking University Institute of Mental Health, Key Laboratory of Mental Health, Ministry of Health (Peking University), National Clinical Research Centre for Mental Disorders (Peking University Sixth Hospital), Beijing, China
| |
Collapse
|
41
|
Hong X, Yu H, Wang B. [Progress on influencing factors regarding the neonatal group B streptococcal infectious diseases]. Zhonghua Liu Xing Bing Xue Za Zhi 2018; 39:249-252. [PMID: 29495215 DOI: 10.3760/cma.j.issn.0254-6450.2018.02.022] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Subscribe] [Scholar Register] [Indexed: 11/05/2022]
Abstract
Group B streptococcus (GBS) is one of the severe pathogenic bacteria during the perinatal period, both on pregnant women and newborns. GBS infection may lead to pneumonia, septicemia, meningitis or other severe disease, even death in neonates. Although only 1%-2% infections will develop into GBS disease among the neonates, the etiological mechanism of which is worth researching. This review summarizes the possible factors related to GBS infection or occurrence of the disease, including the risk in gestation period (for example, colonization of GBS on vagina of pregnant women, preterm birth or premature rupture of fetal membranes and so on), related pathogens (bacteria strains, loads or virulence), immune level (inflammatory factor or neutralizing anticytokine auto-Abs), gene defect or primary immunodeficiencies of the hosts.
Collapse
Affiliation(s)
- X Hong
- Department of Epidemiology and Health Statistics, School of Public Health, Southeast University; Key Laboratory of Environmental Medicine Engineering of Ministry of Education, Nanjing 210009, China
| | - H Yu
- Department of Obstetrics, Southeast University Affiliated Zhongda Hospital, Nanjing 210009, China
| | - B Wang
- Department of Epidemiology and Health Statistics, School of Public Health, Southeast University; Key Laboratory of Environmental Medicine Engineering of Ministry of Education, Nanjing 210009, China
| |
Collapse
|
42
|
Yao Z, Qin Z, Lin P, Hong X, Wang L, Dai Y, Yao X. Case study of Allii Macrostemonis Bulbus: From chemical and metabolic profile to quality control by UPLC/Q-TOF-MS. Am J Transl Res 2017. [DOI: 10.1055/s-0037-1608517] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/18/2022]
Affiliation(s)
- Z Yao
- Jinnan University, Guangzhou, China
- Guangdong Provincial Key Laboratory of Pharmacodynamic Constituents of TCM and New Drugs Research, College of Pharmacy, Jinan University, Guangzhou 510632, P.R. China;, Guangzhou, China
| | - Z Qin
- Jinnan University, Guangzhou, China
- Guangdong Provincial Key Laboratory of Pharmacodynamic Constituents of TCM and New Drugs Research, College of Pharmacy, Jinan University, Guangzhou 510632, P.R. China;, Guangzhou, China
| | - P Lin
- Jinnan University, Guangzhou, China
- Guangdong Provincial Key Laboratory of Pharmacodynamic Constituents of TCM and New Drugs Research, College of Pharmacy, Jinan University, Guangzhou 510632, P.R. China;, Guangzhou, China
| | - X Hong
- Jinnan University, Guangzhou, China
- Guangdong Provincial Key Laboratory of Pharmacodynamic Constituents of TCM and New Drugs Research, College of Pharmacy, Jinan University, Guangzhou 510632, P.R. China;, Guangzhou, China
| | - L Wang
- Jinnan University, Guangzhou, China
- Guangdong Provincial Key Laboratory of Pharmacodynamic Constituents of TCM and New Drugs Research, College of Pharmacy, Jinan University, Guangzhou 510632, P.R. China;, Guangzhou, China
| | - Y Dai
- Jinnan University, Guangzhou, China
- Guangdong Provincial Key Laboratory of Pharmacodynamic Constituents of TCM and New Drugs Research, College of Pharmacy, Jinan University, Guangzhou 510632, P.R. China;, Guangzhou, China
| | - X Yao
- Jinnan University, Guangzhou, China
- Guangdong Provincial Key Laboratory of Pharmacodynamic Constituents of TCM and New Drugs Research, College of Pharmacy, Jinan University, Guangzhou 510632, P.R. China;, Guangzhou, China
| |
Collapse
|
43
|
Escolar ML, Kiely BT, Shawgo E, Hong X, Gelb MH, Orsini JJ, Matern D, Poe MD. Psychosine, a marker of Krabbe phenotype and treatment effect. Mol Genet Metab 2017; 121:271-278. [PMID: 28579020 PMCID: PMC5548593 DOI: 10.1016/j.ymgme.2017.05.015] [Citation(s) in RCA: 36] [Impact Index Per Article: 5.1] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 03/27/2017] [Revised: 05/21/2017] [Accepted: 05/21/2017] [Indexed: 10/19/2022]
Abstract
Newborn screening (NBS) for Krabbe disease, a rare neurodegenerative disorder caused by deficient galactocerebrosidase (GALC) enzyme activity, has recently been implemented in a number of US states. However, the spectrum of phenotypic manifestations associated with deficient GALC activity complicates the management of screen-positive newborns and underscores the need to identify clinically relevant biomarkers. Earlier studies with a small number of patients identified psychosine, a substrate of the GALC enzyme, as a potential biomarker for Krabbe disease. In this study, we provide, for the first time, longitudinal data on dried blood spot (DBS) psychosine concentrations in different Krabbe disease phenotypes for both untreated patients and those treated with hematopoietic stem cell transplantation (HSCT). Our cohort included patients previously identified by NBS to be at high risk to develop Krabbe disease. Substantially elevated DBS psychosine concentration during the newborn period was found to be a highly specific marker for infantile Krabbe disease. This finding supports the use of DBS psychosine concentration as a second-tier NBS test to aid in the identification of patients who require urgent evaluation for HSCT. In addition, longitudinal assessments showed that both natural disease progression and treatment with HSCT were associated with decreases in DBS psychosine concentrations. Based on these findings we provide recommendations for the interpretation of psychosine concentrations in DBS specimens collected during the first year of life. Future studies should aim to better delineate the relationship between DBS psychosine concentration and disease onset in patients with later-onset forms of Krabbe disease.
Collapse
Affiliation(s)
- M L Escolar
- Program for the Study of Neurodevelopment in Rare Disorders, Children's Hospital of Pittsburgh of UPMC, Pittsburgh, PA 15224, USA.
| | - B T Kiely
- Program for the Study of Neurodevelopment in Rare Disorders, Children's Hospital of Pittsburgh of UPMC, Pittsburgh, PA 15224, USA
| | - E Shawgo
- Program for the Study of Neurodevelopment in Rare Disorders, Children's Hospital of Pittsburgh of UPMC, Pittsburgh, PA 15224, USA
| | - X Hong
- Departments of Chemistry and Biochemistry, University of Washington, Seattle, WA 98195, USA
| | - M H Gelb
- Departments of Chemistry and Biochemistry, University of Washington, Seattle, WA 98195, USA
| | - J J Orsini
- Newborn Screening Program, Wadsworth Center, New York State Department of Health, Albany, NY 12201, USA
| | - D Matern
- Biochemical Genetics Laboratory, Department of Laboratory Medicine and Pathology, Mayo Clinic, Rochester, MN 55905, USA
| | - M D Poe
- Program for the Study of Neurodevelopment in Rare Disorders, Children's Hospital of Pittsburgh of UPMC, Pittsburgh, PA 15224, USA
| |
Collapse
|
44
|
Feng B, Lu J, Zhang S, Yan X, Li J, Xue P, Wang M, Lu A, Ma J, Zang L, Dong F, He Z, Yue F, Sun J, Hong X, Zheng M. Laparoscopic abdominoperineal excision with trans-abdominal individualized levator transection: interim analysis of a randomized controlled trial. Colorectal Dis 2017; 19:O246-O252. [PMID: 28477432 DOI: 10.1111/codi.13711] [Citation(s) in RCA: 3] [Impact Index Per Article: 0.4] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 09/13/2016] [Accepted: 02/24/2017] [Indexed: 02/08/2023]
Abstract
AIM Extralevator abdominoperineal excision (ELAPR) is challenging 'conventional' abdominoperineal excision (APR), yet the safety and efficacy of ELAPR is still under debate. We therefore developed a laparoscopic APR with trans-abdominal individualized levator transection (LAPR-TILT) approach and compared the outcome with a conventional laparoscopic APR (CLAPR). METHOD All eligible patients were entered a single-centre randomized controlled trial to compare CLAPR and LAPR-TILT. We assessed the first 185 patients, including operative findings, complications, histopathology and urogenital function. RESULTS Ninety-three patients in the CLAPR group and 92 patients in the APR-TILT group were included for analysis. The APR-TILT procedure took less time [137 (101-175) min vs 146 (102-187) min; P = 0.03], mainly owing to faster perineal dissection. APR-TILT resulted in a reduced rate of bowel perforation (1.1% vs 8.6%; P = 0.04), circumferential resection margin positivity (1.1% vs 10.8%; P = 0.01) and postoperative wound complications (5.4% vs 16.2%; P = 0.02) compared with the CLAPR procedure. At a median follow-up of 19 months after surgery, three patients (3.2%) in the CLAPR group had tumour recurrence while no tumour recurrence occurred in the LAPR-TILT group. Patients who underwent LAPR-TILT reported fewer urinary or sexual problems (LAPR-TILT vs CLAPR, 10.9% vs 24.7% and 17.4% vs 38.7%, respectively). CONCLUSION Compared with CLAPR, LAPR-TILT achieved better pathological results for factors that are surrogate parameters for local recurrence. LAPR-TILT could also reduce the risk of urogenital dysfunction.
Collapse
Affiliation(s)
- B Feng
- Department of Surgery, Ruijin Hospital, Shanghai Jiao Tong University School of Medicine, and Shanghai Minimally Invasive Surgery Center, Shanghai, China
| | - J Lu
- Department of Surgery, Ruijin Hospital, Shanghai Jiao Tong University School of Medicine, and Shanghai Minimally Invasive Surgery Center, Shanghai, China
| | - S Zhang
- Department of Surgery, Ruijin Hospital, Shanghai Jiao Tong University School of Medicine, and Shanghai Minimally Invasive Surgery Center, Shanghai, China
| | - X Yan
- Department of Surgery, Ruijin Hospital, Shanghai Jiao Tong University School of Medicine, and Shanghai Minimally Invasive Surgery Center, Shanghai, China
| | - J Li
- Department of Surgery, Ruijin Hospital, Shanghai Jiao Tong University School of Medicine, and Shanghai Minimally Invasive Surgery Center, Shanghai, China
| | - P Xue
- Department of Surgery, Ruijin Hospital, Shanghai Jiao Tong University School of Medicine, and Shanghai Minimally Invasive Surgery Center, Shanghai, China
| | - M Wang
- Department of Surgery, Ruijin Hospital, Shanghai Jiao Tong University School of Medicine, and Shanghai Minimally Invasive Surgery Center, Shanghai, China
| | - A Lu
- Department of Surgery, Ruijin Hospital, Shanghai Jiao Tong University School of Medicine, and Shanghai Minimally Invasive Surgery Center, Shanghai, China
| | - J Ma
- Department of Surgery, Ruijin Hospital, Shanghai Jiao Tong University School of Medicine, and Shanghai Minimally Invasive Surgery Center, Shanghai, China
| | - L Zang
- Department of Surgery, Ruijin Hospital, Shanghai Jiao Tong University School of Medicine, and Shanghai Minimally Invasive Surgery Center, Shanghai, China
| | - F Dong
- Department of Surgery, Ruijin Hospital, Shanghai Jiao Tong University School of Medicine, and Shanghai Minimally Invasive Surgery Center, Shanghai, China
| | - Z He
- Department of Surgery, Ruijin Hospital, Shanghai Jiao Tong University School of Medicine, and Shanghai Minimally Invasive Surgery Center, Shanghai, China
| | - F Yue
- Department of Surgery, Ruijin Hospital, Shanghai Jiao Tong University School of Medicine, and Shanghai Minimally Invasive Surgery Center, Shanghai, China
| | - J Sun
- Department of Surgery, Ruijin Hospital, Shanghai Jiao Tong University School of Medicine, and Shanghai Minimally Invasive Surgery Center, Shanghai, China
| | - X Hong
- Department of Surgery, Ruijin Hospital, Shanghai Jiao Tong University School of Medicine, and Shanghai Minimally Invasive Surgery Center, Shanghai, China
| | - M Zheng
- Department of Surgery, Ruijin Hospital, Shanghai Jiao Tong University School of Medicine, and Shanghai Minimally Invasive Surgery Center, Shanghai, China
| |
Collapse
|
45
|
Kostakoglu L, Martelli M, Belada D, Carella A, Chua N, Gonzalez-Barca E, Hong X, Pinto A, Sehn L, Shi Y, Tatsumi Y, Fingerle-Rowson G, Mattiello F, Nielsen T, Sahin D, Vitolo U, Trněný M. END OF TREATMENT PET-CT PREDICTS PROGRESSION-FREE SURVIVAL IN DLBCL AFTER FIRST-LINE TREATMENT: RESULTS FROM THE PHASE III GOYA STUDY. Hematol Oncol 2017. [DOI: 10.1002/hon.2438_45] [Citation(s) in RCA: 3] [Impact Index Per Article: 0.4] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/10/2022]
Affiliation(s)
- L. Kostakoglu
- Department of Radiology; Icahn School of Medicine at Mount Sinai; New York USA
| | - M. Martelli
- Department of Cellular Biotechnologies and Hematology; Sapienza University; Rome Italy
| | - D. Belada
- 4th Department of Internal Medicine-Hematology; University Hospital Hradec Kralove, and Charles University in Prague, Faculty of Medicine in Hradec Kralove; Hradec Kralove Czech Republic
| | - A.M. Carella
- U.O. Hematology I; IRCCS AO University, San Martino-IST; Genoa Italy
| | - N. Chua
- Cross Cancer Institute; University of Alberta; Edmonton Canada
| | - E. Gonzalez-Barca
- Institut Catalá d'Oncologia Hospitalet, IDIBELL; University of Barcelona; Barcelona Spain
| | - X. Hong
- Department of Medical Oncology; Fudan University Shanghai Cancer Center; Shanghai China
| | - A. Pinto
- Istituto Nazionale Tumori, Fondazione G. Pascale; IRCCS; Naples Italy
| | - L.H. Sehn
- Centre for Lymphoid Cancer; British Columbia Cancer Agency and the University of British Columbia; Vancouver Canada
| | - Y. Shi
- National Cancer Center, Chinese Academy of Medical Sciences and Peking Union Medical College; Beijing Key Laboratory of Clinical Study on Anticancer Molecular Targeted Drugs; Beijing China
| | - Y. Tatsumi
- Department of Hematology and Rheumatology, Faculty of Medicine; Kinki University Hospital; Osaka Japan
| | - G. Fingerle-Rowson
- Pharma Development Clinical Oncology; F. Hoffmann-La Roche Ltd; Basel Switzerland
| | - F. Mattiello
- Pharma Development Biometrics Biostatistics; F. Hoffmann-La Roche Ltd; Basel Switzerland
| | - T. Nielsen
- Pharma Development Clinical Oncology; F. Hoffmann-La Roche Ltd; Basel Switzerland
| | - D. Sahin
- Department of Hematology and Rheumatology, Faculty of Medicine; Kinki University Hospital; Osaka Japan
| | - U. Vitolo
- Department of Hematology; Azienda Ospedaliera Universitaria Città della Salute e della Scienza di Torino; Turin Italy
| | - M. Trněný
- Department of Medicine-Department of Hematology; Charles University; Prague Czech Republic
| |
Collapse
|
46
|
Xia Z, Lv F, Xue K, Zhang Q, Ji D, Cao J, Hong X, Guo Y. PEGYLATED LIPOSOMAL DOXORUBICIN COMBINED WITH CYCLOPHOSPHAMIDE, VINCRISTINE/VINDESINE, AND PREDNISONE IN PATIENTS WITH AGGRESSIVE T-CELL LYMPHOMA: PRELIMINARY RESULTS OF APHASE II STUDY. Hematol Oncol 2017. [DOI: 10.1002/hon.2439_162] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/06/2022]
Affiliation(s)
- Z. Xia
- Medical Oncology; Fudan University Shanghai Cancer Center; Shanghai China
| | - F. Lv
- Medical Oncology; Fudan University Shanghai Cancer Center; Shanghai China
| | - K. Xue
- Medical Oncology; Fudan University Shanghai Cancer Center; Shanghai China
| | - Q. Zhang
- Medical Oncology; Fudan University Shanghai Cancer Center; Shanghai China
| | - D. Ji
- Medical Oncology; Fudan University Shanghai Cancer Center; Shanghai China
| | - J. Cao
- Medical Oncology; Fudan University Shanghai Cancer Center; Shanghai China
| | - X. Hong
- Medical Oncology; Fudan University Shanghai Cancer Center; Shanghai China
| | - Y. Guo
- Medical Oncology; Fudan University Shanghai Cancer Center; Shanghai China
| |
Collapse
|
47
|
Li C, Ma X, Pan Z, Lv F, Xia Z, Xue K, Zhang Q, Ji D, Cao J, Hong X, Guo Y. Consolidation radiotherapy does not improve the outcome as compared with chemotherapy alone in patients with limited stage diffuse large B-cell lymphoma of Waldeyer's ring. Hematol Oncol 2017. [DOI: 10.1002/hon.2439_76] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/08/2022]
Affiliation(s)
- C. Li
- Department of Medical Oncology; Fudan University Shanghai Cancer Center; Shanghai China
| | - X. Ma
- Department of Radiation Oncology; Fudan University Shanghai Cancer Center; Shanghai China
| | - Z. Pan
- Department of Radiation Oncology; Fudan University Shanghai Cancer Center; Shanghai China
| | - F. Lv
- Department of Medical Oncology; Fudan University Shanghai Cancer Center; Shanghai China
| | - Z. Xia
- Department of Medical Oncology; Fudan University Shanghai Cancer Center; Shanghai China
| | - K. Xue
- Department of Medical Oncology; Fudan University Shanghai Cancer Center; Shanghai China
| | - Q. Zhang
- Department of Medical Oncology; Fudan University Shanghai Cancer Center; Shanghai China
| | - D. Ji
- Department of Medical Oncology; Fudan University Shanghai Cancer Center; Shanghai China
| | - J. Cao
- Department of Medical Oncology; Fudan University Shanghai Cancer Center; Shanghai China
| | - X. Hong
- Department of Medical Oncology; Fudan University Shanghai Cancer Center; Shanghai China
| | - Y. Guo
- Department of Medical Oncology; Fudan University Shanghai Cancer Center; Shanghai China
| |
Collapse
|
48
|
Lv F, Xia Z, Xue K, Zhang Q, Ji D, Cao J, Hong X, Guo Y. Preliminary results of a phase II study using response-adapted therapy for limited-stage diffuse large B-cell lymphoma based on interim PET/CT. Hematol Oncol 2017. [DOI: 10.1002/hon.2439_34] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/10/2022]
Affiliation(s)
- F. Lv
- Medical Oncology; Fudan University Shanghai Cancer Center; Shanghai China
| | - Z. Xia
- Medical Oncology; Fudan University Shanghai Cancer Center; Shanghai China
| | - K. Xue
- Medical Oncology; Fudan University Shanghai Cancer Center; Shanghai China
| | - Q. Zhang
- Medical Oncology; Fudan University Shanghai Cancer Center; Shanghai China
| | - D. Ji
- Medical Oncology; Fudan University Shanghai Cancer Center; Shanghai China
| | - J. Cao
- Medical Oncology; Fudan University Shanghai Cancer Center; Shanghai China
| | - X. Hong
- Medical Oncology; Fudan University Shanghai Cancer Center; Shanghai China
| | - Y. Guo
- Medical Oncology; Fudan University Shanghai Cancer Center; Shanghai China
| |
Collapse
|
49
|
Affiliation(s)
- T M Frisoli
- Department of Cardiology, Henry Ford Hospital, Detroit, MI, USA.
| | - T Jain
- Department of Cardiology, Henry Ford Hospital, Detroit, MI, USA
| | - T Swadia
- Department of Cardiology, Michigan Heart, St Joseph Mercy Health System, Livonia, MI, USA
| | - X Hong
- Department of Radiology, Henry Ford Hospital, Detroit, MI, USA
| | - M Guerrero
- Department of Cardiology, Evanston Hospital, North Shore University Health System, Evanston, IL, USA
| |
Collapse
|
50
|
Hong XY, Hong X, Gu WW, Lin J, Yin WT. Femoral nerve repair using an H-type nerve regeneration chamber in rats. J BIOL REG HOMEOS AG 2017; 31. [PMID: 28387110] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 06/07/2023]
Abstract
Peripheral nerve injury in surgical trauma patients is very common. The femoral nerve can be divided into two branches: one regarding the quadricep muscles, and one the skin. After nerve transection and suture, the motor axons have an equal opportunity to regenerate into the original muscle branch, or regenerate into the sensory skin nerves. These anatomical features of femoral nerve have made it important in nerve regeneration research. Thus, this study was designed to examine the effects of an H-type nerve regeneration chamber on motor nerve regeneration after femoral nerve injury. We performed femoral nerve injuries in adult rats and assessed nerve recovery over a 4-week post-operative period. Additionally, we evaluated nerve regeneration in the same animals anatomically, using several histological staining methods to provide structure analyses. We found that H-type nerve regeneration chamber provided enhanced improvement in nerve regeneration without nerve anastomosis, as compared with nerve anastomosis. Furthermore, incorrect nerve anastomosis reduced the nerve fiber diameter and thickness of myelin sheaths in regenerated nerve fibers. Finally, H-type nerve regeneration chamber provided enhanced functional recovery of nerve fibers, particularly for motor nerves. Together, our results suggest that direct nerve suture cannot effectively improve the functional recovery of damaged nerves, and nerve chemotaxis coupled with nerve regeneration chamber can effectively improve the effects of nerve regeneration, and enhance the prognosis of nerve injury repair.
Collapse
Affiliation(s)
- X Y Hong
- Department of Vascular Surgery, China-Japan Union Hospital of Jilin University, Changchun, China
| | - X Hong
- Department of Vascular Surgery, China-Japan Union Hospital of Jilin University, Changchun, China
| | - W W Gu
- Department of Hepatopancreatobility Surgery, China-Japan Union Hospital of Jilin University, Changchun, China
| | - J Lin
- Department of Vascular Surgery, China-Japan Union Hospital of Jilin University, Changchun, China
| | - W T Yin
- Department of Hand Surgery, China-Japan Union Hospital of Jilin University, Changchun, China
| |
Collapse
|